Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade

T cell dysfunction is a hallmark of many cancers, but the basis for T cell dysfunction and the mechanisms by which antibody blockade of the inhibitory receptor PD-1 (anti-PD-1) reinvigorates T cells are not fully understood. Here we show that such therapy acts on a specific subpopulation of exhauste...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature immunology Jg. 20; H. 3; S. 326 - 336
Hauptverfasser:	Miller, Brian C., Sen, Debattama R., Al Abosy, Rose, Bi, Kevin, Virkud, Yamini V., LaFleur, Martin W., Yates, Kathleen B., Lako, Ana, Felt, Kristen, Naik, Girish S., Manos, Michael, Gjini, Evisa, Kuchroo, Juhi R., Ishizuka, Jeffrey J., Collier, Jenna L., Griffin, Gabriel K., Maleri, Seth, Comstock, Dawn E., Weiss, Sarah A., Brown, Flavian D., Panda, Arpit, Zimmer, Margaret D., Manguso, Robert T., Hodi, F. Stephen, Rodig, Scott J., Sharpe, Arlene H., Haining, W. Nicholas
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	New York Nature Publishing Group US 01.03.2019 Nature Publishing Group
Schlagworte:	631/250/1619/554/1834/1269 631/250/2502/2170 631/250/580 692/699/67/1059/2325 Animals Antibodies, Blocking - immunology Antibodies, Blocking - pharmacology Biomedical and Life Sciences Biomedicine CD8 antigen CD8-Positive T-Lymphocytes - drug effects CD8-Positive T-Lymphocytes - immunology CD8-Positive T-Lymphocytes - virology Cell Line, Tumor Chronic infection Cytotoxicity Epigenetics Female Humans Immune checkpoint Immunology Infectious Diseases Lymphocyte Subsets - drug effects Lymphocyte Subsets - immunology Lymphocyte Subsets - virology Lymphocytes Lymphocytes T Lymphocytes, Tumor-Infiltrating - drug effects Lymphocytes, Tumor-Infiltrating - immunology Lymphocytes, Tumor-Infiltrating - virology Lymphocytic Choriomeningitis - immunology Lymphocytic Choriomeningitis - prevention & control Lymphocytic Choriomeningitis - virology Lymphocytic choriomeningitis virus - drug effects Lymphocytic choriomeningitis virus - immunology Lymphocytic choriomeningitis virus - physiology Melanoma Melanoma, Experimental - immunology Melanoma, Experimental - prevention & control Melanoma, Experimental - virology Mice, Congenic Mice, Inbred C57BL PD-1 protein Programmed Cell Death 1 Receptor - antagonists & inhibitors Programmed Cell Death 1 Receptor - immunology Programmed Cell Death 1 Receptor - metabolism Transcription Tumor-infiltrating lymphocytes
ISSN:	1529-2908, 1529-2916, 1529-2916
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Abstract	T cell dysfunction is a hallmark of many cancers, but the basis for T cell dysfunction and the mechanisms by which antibody blockade of the inhibitory receptor PD-1 (anti-PD-1) reinvigorates T cells are not fully understood. Here we show that such therapy acts on a specific subpopulation of exhausted CD8 + tumor-infiltrating lymphocytes (TILs). Dysfunctional CD8 + TILs possess canonical epigenetic and transcriptional features of exhaustion that mirror those seen in chronic viral infection. Exhausted CD8 + TILs include a subpopulation of ‘progenitor exhausted’ cells that retain polyfunctionality, persist long term and differentiate into ‘terminally exhausted’ TILs. Consequently, progenitor exhausted CD8 + TILs are better able to control tumor growth than are terminally exhausted T cells. Progenitor exhausted TILs can respond to anti-PD-1 therapy, but terminally exhausted TILs cannot. Patients with melanoma who have a higher percentage of progenitor exhausted cells experience a longer duration of response to checkpoint-blockade therapy. Thus, approaches to expand the population of progenitor exhausted CD8 + T cells might be an important component of improving the response to checkpoint blockade. Exhausted cytotoxic T lymphocytes (CTLs) express the receptor PD-1 as a key signature. Haining and colleagues show that there are different ‘depths’ of exhaustion with a subset of exhausted CTLs that retain polyfunctionality and are responsive to PD-1 blockade.
AbstractList	T cell dysfunction is a hallmark of many cancers, but the basis for T cell dysfunction and the mechanisms by which antibody blockade of the inhibitory receptor PD-1 (anti-PD-1) reinvigorates T cells are not fully understood. Here we show that such therapy acts on a specific subpopulation of exhausted CD8+ tumor-infiltrating lymphocytes (TILs). Dysfunctional CD8+ TILs possess canonical epigenetic and transcriptional features of exhaustion that mirror those seen in chronic viral infection. Exhausted CD8+ TILs include a subpopulation of ‘progenitor exhausted’ cells that retain polyfunctionality, persist long term and differentiate into ‘terminally exhausted’ TILs. Consequently, progenitor exhausted CD8+ TILs are better able to control tumor growth than are terminally exhausted T cells. Progenitor exhausted TILs can respond to anti-PD-1 therapy, but terminally exhausted TILs cannot. Patients with melanoma who have a higher percentage of progenitor exhausted cells experience a longer duration of response to checkpoint-blockade therapy. Thus, approaches to expand the population of progenitor exhausted CD8+ T cells might be an important component of improving the response to checkpoint blockade.Exhausted cytotoxic T lymphocytes (CTLs) express the receptor PD-1 as a key signature. Haining and colleagues show that there are different ‘depths’ of exhaustion with a subset of exhausted CTLs that retain polyfunctionality and are responsive to PD-1 blockade. T cell dysfunction is a hallmark of many cancers, but the basis for T cell dysfunction and the mechanisms by which antibody blockade of the inhibitory receptor PD-1 (anti-PD-1) reinvigorates T cells are not fully understood. Here we show that such therapy acts on a specific subpopulation of exhausted CD8+ tumor-infiltrating lymphocytes (TILs). Dysfunctional CD8+ TILs possess canonical epigenetic and transcriptional features of exhaustion that mirror those seen in chronic viral infection. Exhausted CD8+ TILs include a subpopulation of ‘progenitor exhausted’ cells that retain polyfunctionality, persist long term and differentiate into ‘terminally exhausted’ TILs. Consequently, progenitor exhausted CD8+ TILs are better able to control tumor growth than are terminally exhausted T cells. Progenitor exhausted TILs can respond to anti-PD-1 therapy, but terminally exhausted TILs cannot. Patients with melanoma who have a higher percentage of progenitor exhausted cells experience a longer duration of response to checkpoint-blockade therapy. Thus, approaches to expand the population of progenitor exhausted CD8+ T cells might be an important component of improving the response to checkpoint blockade. T cell dysfunction is a hallmark of many cancers, but the basis for T cell dysfunction and the mechanisms by which antibody blockade of the inhibitory receptor PD-1 (anti-PD-1) reinvigorates T cells are not fully understood. Here we show that such therapy acts on a specific subpopulation of exhausted CD8+ tumor-infiltrating lymphocytes (TILs). Dysfunctional CD8+ TILs possess canonical epigenetic and transcriptional features of exhaustion that mirror those seen in chronic viral infection. Exhausted CD8+ TILs include a subpopulation of 'progenitor exhausted' cells that retain polyfunctionality, persist long term and differentiate into 'terminally exhausted' TILs. Consequently, progenitor exhausted CD8+ TILs are better able to control tumor growth than are terminally exhausted T cells. Progenitor exhausted TILs can respond to anti-PD-1 therapy, but terminally exhausted TILs cannot. Patients with melanoma who have a higher percentage of progenitor exhausted cells experience a longer duration of response to checkpoint-blockade therapy. Thus, approaches to expand the population of progenitor exhausted CD8+ T cells might be an important component of improving the response to checkpoint blockade.T cell dysfunction is a hallmark of many cancers, but the basis for T cell dysfunction and the mechanisms by which antibody blockade of the inhibitory receptor PD-1 (anti-PD-1) reinvigorates T cells are not fully understood. Here we show that such therapy acts on a specific subpopulation of exhausted CD8+ tumor-infiltrating lymphocytes (TILs). Dysfunctional CD8+ TILs possess canonical epigenetic and transcriptional features of exhaustion that mirror those seen in chronic viral infection. Exhausted CD8+ TILs include a subpopulation of 'progenitor exhausted' cells that retain polyfunctionality, persist long term and differentiate into 'terminally exhausted' TILs. Consequently, progenitor exhausted CD8+ TILs are better able to control tumor growth than are terminally exhausted T cells. Progenitor exhausted TILs can respond to anti-PD-1 therapy, but terminally exhausted TILs cannot. Patients with melanoma who have a higher percentage of progenitor exhausted cells experience a longer duration of response to checkpoint-blockade therapy. Thus, approaches to expand the population of progenitor exhausted CD8+ T cells might be an important component of improving the response to checkpoint blockade. T cell dysfunction is a hallmark of many cancers, but the basis for T cell dysfunction and the mechanisms by which antibody blockade of the inhibitory receptor PD-1 (anti-PD-1) reinvigorates T cells are not fully understood. Here we show that such therapy acts on a specific subpopulation of exhausted CD8 tumor-infiltrating lymphocytes (TILs). Dysfunctional CD8 TILs possess canonical epigenetic and transcriptional features of exhaustion that mirror those seen in chronic viral infection. Exhausted CD8 TILs include a subpopulation of 'progenitor exhausted' cells that retain polyfunctionality, persist long term and differentiate into 'terminally exhausted' TILs. Consequently, progenitor exhausted CD8 TILs are better able to control tumor growth than are terminally exhausted T cells. Progenitor exhausted TILs can respond to anti-PD-1 therapy, but terminally exhausted TILs cannot. Patients with melanoma who have a higher percentage of progenitor exhausted cells experience a longer duration of response to checkpoint-blockade therapy. Thus, approaches to expand the population of progenitor exhausted CD8 T cells might be an important component of improving the response to checkpoint blockade. T cell dysfunction is a hallmark of many cancers, but the basis for T cell dysfunction and the mechanisms by which antibody blockade of the inhibitory receptor PD-1 (anti-PD-1) reinvigorates T cells are not fully understood. Here we show that such therapy acts on a specific subpopulation of exhausted CD8 + tumor-infiltrating lymphocytes (TILs). Dysfunctional CD8 + TILs possess canonical epigenetic and transcriptional features of exhaustion that mirror those seen in chronic viral infection. Exhausted CD8 + TILs include a subpopulation of ‘progenitor exhausted’ cells that retain polyfunctionality, persist long term and differentiate into ‘terminally exhausted’ TILs. Consequently, progenitor exhausted CD8 + TILs are better able to control tumor growth than are terminally exhausted T cells. Progenitor exhausted TILs can respond to anti-PD-1 therapy, but terminally exhausted TILs cannot. Patients with melanoma who have a higher percentage of progenitor exhausted cells experience a longer duration of response to checkpoint-blockade therapy. Thus, approaches to expand the population of progenitor exhausted CD8 + T cells might be an important component of improving the response to checkpoint blockade. Exhausted cytotoxic T lymphocytes (CTLs) express the receptor PD-1 as a key signature. Haining and colleagues show that there are different ‘depths’ of exhaustion with a subset of exhausted CTLs that retain polyfunctionality and are responsive to PD-1 blockade.
Author	Panda, Arpit Hodi, F. Stephen Sharpe, Arlene H. Collier, Jenna L. LaFleur, Martin W. Manguso, Robert T. Ishizuka, Jeffrey J. Haining, W. Nicholas Bi, Kevin Brown, Flavian D. Al Abosy, Rose Sen, Debattama R. Felt, Kristen Kuchroo, Juhi R. Weiss, Sarah A. Zimmer, Margaret D. Lako, Ana Manos, Michael Rodig, Scott J. Naik, Girish S. Comstock, Dawn E. Griffin, Gabriel K. Yates, Kathleen B. Virkud, Yamini V. Miller, Brian C. Gjini, Evisa Maleri, Seth
AuthorAffiliation	3 Broad Institute of MIT and Harvard, Cambridge, MA, USA 4 Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women’s Hospital, Boston, MA, USA 6 Division of Medical Sciences, Harvard Medical School, Boston, MA, USA 10 These authors contributed equally: Brian C. Miller, Debattama R. Sen 8 Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA 9 Department of Pathology, Brigham and Women’s Hospital, Boston, MA, USA 1 Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA 5 Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA 7 Division of Pediatric Allergy and Immunology, Massachusetts General Hospital, Boston, MA, USA 2 Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
AuthorAffiliation_xml	– name: 2 Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA – name: 5 Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA – name: 10 These authors contributed equally: Brian C. Miller, Debattama R. Sen – name: 1 Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA – name: 3 Broad Institute of MIT and Harvard, Cambridge, MA, USA – name: 9 Department of Pathology, Brigham and Women’s Hospital, Boston, MA, USA – name: 7 Division of Pediatric Allergy and Immunology, Massachusetts General Hospital, Boston, MA, USA – name: 4 Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women’s Hospital, Boston, MA, USA – name: 6 Division of Medical Sciences, Harvard Medical School, Boston, MA, USA – name: 8 Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
Author_xml	– sequence: 1 givenname: Brian C. orcidid: 0000-0001-5931-4184 surname: Miller fullname: Miller, Brian C. organization: Department of Pediatric Oncology, Dana-Farber Cancer Institute, Department of Medical Oncology, Dana-Farber Cancer Institute, Broad Institute of MIT and Harvard, Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women’s Hospital, Department of Immunology, Blavatnik Institute, Harvard Medical School – sequence: 2 givenname: Debattama R. orcidid: 0000-0002-0947-8284 surname: Sen fullname: Sen, Debattama R. organization: Department of Pediatric Oncology, Dana-Farber Cancer Institute, Broad Institute of MIT and Harvard, Division of Medical Sciences, Harvard Medical School – sequence: 3 givenname: Rose orcidid: 0000-0001-5400-1306 surname: Al Abosy fullname: Al Abosy, Rose organization: Department of Pediatric Oncology, Dana-Farber Cancer Institute, Broad Institute of MIT and Harvard – sequence: 4 givenname: Kevin surname: Bi fullname: Bi, Kevin organization: Department of Pediatric Oncology, Dana-Farber Cancer Institute, Broad Institute of MIT and Harvard – sequence: 5 givenname: Yamini V. surname: Virkud fullname: Virkud, Yamini V. organization: Division of Pediatric Allergy and Immunology, Massachusetts General Hospital – sequence: 6 givenname: Martin W. orcidid: 0000-0002-5017-774X surname: LaFleur fullname: LaFleur, Martin W. organization: Department of Pediatric Oncology, Dana-Farber Cancer Institute, Broad Institute of MIT and Harvard, Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women’s Hospital, Department of Immunology, Blavatnik Institute, Harvard Medical School, Division of Medical Sciences, Harvard Medical School – sequence: 7 givenname: Kathleen B. surname: Yates fullname: Yates, Kathleen B. organization: Department of Pediatric Oncology, Dana-Farber Cancer Institute, Broad Institute of MIT and Harvard – sequence: 8 givenname: Ana surname: Lako fullname: Lako, Ana organization: Center for Immuno-Oncology, Dana-Farber Cancer Institute – sequence: 9 givenname: Kristen surname: Felt fullname: Felt, Kristen organization: Center for Immuno-Oncology, Dana-Farber Cancer Institute – sequence: 10 givenname: Girish S. surname: Naik fullname: Naik, Girish S. organization: Center for Immuno-Oncology, Dana-Farber Cancer Institute – sequence: 11 givenname: Michael surname: Manos fullname: Manos, Michael organization: Department of Medical Oncology, Dana-Farber Cancer Institute, Center for Immuno-Oncology, Dana-Farber Cancer Institute – sequence: 12 givenname: Evisa surname: Gjini fullname: Gjini, Evisa organization: Department of Medical Oncology, Dana-Farber Cancer Institute, Center for Immuno-Oncology, Dana-Farber Cancer Institute – sequence: 13 givenname: Juhi R. surname: Kuchroo fullname: Kuchroo, Juhi R. organization: Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women’s Hospital, Department of Immunology, Blavatnik Institute, Harvard Medical School, Division of Medical Sciences, Harvard Medical School – sequence: 14 givenname: Jeffrey J. surname: Ishizuka fullname: Ishizuka, Jeffrey J. organization: Department of Pediatric Oncology, Dana-Farber Cancer Institute, Department of Medical Oncology, Dana-Farber Cancer Institute, Broad Institute of MIT and Harvard – sequence: 15 givenname: Jenna L. orcidid: 0000-0002-4071-4986 surname: Collier fullname: Collier, Jenna L. organization: Department of Pediatric Oncology, Dana-Farber Cancer Institute, Broad Institute of MIT and Harvard, Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women’s Hospital, Department of Immunology, Blavatnik Institute, Harvard Medical School, Division of Medical Sciences, Harvard Medical School – sequence: 16 givenname: Gabriel K. surname: Griffin fullname: Griffin, Gabriel K. organization: Department of Pediatric Oncology, Dana-Farber Cancer Institute, Broad Institute of MIT and Harvard, Department of Pathology, Brigham and Women’s Hospital – sequence: 17 givenname: Seth surname: Maleri fullname: Maleri, Seth organization: Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women’s Hospital, Department of Immunology, Blavatnik Institute, Harvard Medical School – sequence: 18 givenname: Dawn E. surname: Comstock fullname: Comstock, Dawn E. organization: Department of Pediatric Oncology, Dana-Farber Cancer Institute, Broad Institute of MIT and Harvard, Division of Medical Sciences, Harvard Medical School – sequence: 19 givenname: Sarah A. surname: Weiss fullname: Weiss, Sarah A. organization: Department of Pediatric Oncology, Dana-Farber Cancer Institute, Broad Institute of MIT and Harvard, Division of Medical Sciences, Harvard Medical School – sequence: 20 givenname: Flavian D. surname: Brown fullname: Brown, Flavian D. organization: Department of Pediatric Oncology, Dana-Farber Cancer Institute, Broad Institute of MIT and Harvard, Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women’s Hospital, Department of Immunology, Blavatnik Institute, Harvard Medical School, Division of Medical Sciences, Harvard Medical School – sequence: 21 givenname: Arpit surname: Panda fullname: Panda, Arpit organization: Department of Pediatric Oncology, Dana-Farber Cancer Institute, Broad Institute of MIT and Harvard – sequence: 22 givenname: Margaret D. surname: Zimmer fullname: Zimmer, Margaret D. organization: Broad Institute of MIT and Harvard – sequence: 23 givenname: Robert T. surname: Manguso fullname: Manguso, Robert T. organization: Broad Institute of MIT and Harvard – sequence: 24 givenname: F. Stephen surname: Hodi fullname: Hodi, F. Stephen organization: Department of Medical Oncology, Dana-Farber Cancer Institute, Center for Immuno-Oncology, Dana-Farber Cancer Institute – sequence: 25 givenname: Scott J. surname: Rodig fullname: Rodig, Scott J. organization: Center for Immuno-Oncology, Dana-Farber Cancer Institute, Department of Pathology, Brigham and Women’s Hospital – sequence: 26 givenname: Arlene H. surname: Sharpe fullname: Sharpe, Arlene H. organization: Broad Institute of MIT and Harvard, Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women’s Hospital, Department of Immunology, Blavatnik Institute, Harvard Medical School, Division of Medical Sciences, Harvard Medical School – sequence: 27 givenname: W. Nicholas orcidid: 0000-0001-7871-3762 surname: Haining fullname: Haining, W. Nicholas email: wnhaining@gmail.com organization: Department of Pediatric Oncology, Dana-Farber Cancer Institute, Broad Institute of MIT and Harvard, Division of Medical Sciences, Harvard Medical School
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/30778252$$D View this record in MEDLINE/PubMed
BookMark	eNp9kltrFTEUhYNU7EV_gC8S8EWQ0dwmmXkRyvEKBR-sz2GfzE5P2jmTY5IR--_NcNqqBfu0Q_a3FyvZ65gcTHFCQp5z9oYz2b3Nirc9axjvGya5aPQjcsRb0Tei5_rg7sy6Q3Kc8yVjXBmtnpBDyYzpRCuOSPg2rzOWTKOn-GsDcy440NX77jU9pw7HMdMheI8JpxJgHK_pFocABWmZtzFRF6eS4khhGmjCvIu1lkjdBt3VLoap0PUY3RUM-JQ89jBmfHZTT8j3jx_OV5-bs6-fvqxOzxqn-q40LUrZKeZhzSVI0Lw33rDeuAGEYz24DrxaaxTSe95yJ-odDIobgxpBMHlC3u11d_O6enXVeILR7lLYQrq2EYL9tzOFjb2IP63WRup2EXh1I5DijxlzsduQl6-ACeOcreDdwvVcVPTlPfQyzmmqz7NCmZa1narwQ1RtG8Wl0pV68bfvO8O3u6qA2QMuxZwTeutCgRKWDUAYLWd2SYXdp8LWVNglFXaR5vcmb8UfmhH7mVzZ6QLTH9P_H_oNFDjJdA
CitedBy_id	crossref_primary_10_1038_s41577_025_01161_6 crossref_primary_10_1038_s41586_022_05105_1 crossref_primary_10_1038_s41556_022_00942_8 crossref_primary_10_1038_s41698_022_00263_x crossref_primary_10_1021_jacs_4c04331 crossref_primary_10_1158_1541_7786_MCR_23_0993 crossref_primary_10_1016_j_bbadis_2025_168025 crossref_primary_10_1016_j_tranon_2022_101614 crossref_primary_10_1111_bjd_20405 crossref_primary_10_1111_cas_15331 crossref_primary_10_1158_2326_6066_CIR_23_0005 crossref_primary_10_1016_j_immuni_2024_08_014 crossref_primary_10_1126_science_aay0524 crossref_primary_10_1016_j_biopha_2020_109996 crossref_primary_10_1016_j_pccm_2022_11_001 crossref_primary_10_3389_fimmu_2023_1267816 crossref_primary_10_1002_advs_202508692 crossref_primary_10_1016_j_it_2019_04_002 crossref_primary_10_3389_fimmu_2023_1169144 crossref_primary_10_1016_j_omto_2022_09_001 crossref_primary_10_1016_j_xcrm_2025_101973 crossref_primary_10_1186_s12929_022_00894_z crossref_primary_10_1186_s40364_025_00807_w crossref_primary_10_1136_jitc_2021_002432 crossref_primary_10_1038_s41565_024_01758_3 crossref_primary_10_1016_j_cell_2024_05_038 crossref_primary_10_1016_j_ccell_2024_12_001 crossref_primary_10_1016_j_transci_2025_104117 crossref_primary_10_1038_s41590_024_01963_1 crossref_primary_10_3389_fonc_2022_1024362 crossref_primary_10_1016_j_it_2021_09_002 crossref_primary_10_1146_annurev_med_060619_022830 crossref_primary_10_1016_j_coi_2024_102506 crossref_primary_10_1016_j_it_2024_07_001 crossref_primary_10_1016_j_immuni_2022_12_002 crossref_primary_10_1016_j_immuni_2019_05_013 crossref_primary_10_1016_j_immuni_2022_12_001 crossref_primary_10_1186_s12967_023_04600_x crossref_primary_10_1016_j_cytogfr_2023_09_005 crossref_primary_10_1096_fj_202002566R crossref_primary_10_1038_s41590_020_00817_w crossref_primary_10_1016_j_jhep_2025_01_027 crossref_primary_10_1158_2326_6066_CIR_24_0091 crossref_primary_10_1016_j_immuni_2022_12_006 crossref_primary_10_1016_j_it_2022_04_010 crossref_primary_10_1016_j_xcrm_2024_101686 crossref_primary_10_1172_JCI171310 crossref_primary_10_3390_cancers17071059 crossref_primary_10_1002_jbio_202300374 crossref_primary_10_1038_s41590_024_01843_8 crossref_primary_10_1182_bloodadvances_2023010502 crossref_primary_10_1038_s41590_022_01194_2 crossref_primary_10_3389_fonc_2021_672747 crossref_primary_10_1038_s41571_024_00969_w crossref_primary_10_1016_j_cell_2024_04_023 crossref_primary_10_1016_j_phrs_2020_104876 crossref_primary_10_1016_j_annonc_2023_12_011 crossref_primary_10_1016_j_cell_2024_04_025 crossref_primary_10_3389_fimmu_2021_656010 crossref_primary_10_1038_s41586_020_2056_8 crossref_primary_10_3390_ijms22179401 crossref_primary_10_3389_fimmu_2023_1181499 crossref_primary_10_1007_s40257_024_00907_7 crossref_primary_10_3389_fimmu_2024_1357333 crossref_primary_10_1038_s41416_021_01353_6 crossref_primary_10_3389_fmicb_2022_880873 crossref_primary_10_1007_s00432_022_04147_2 crossref_primary_10_1038_s41416_024_02712_9 crossref_primary_10_1038_s41551_023_01060_y crossref_primary_10_1126_scitranslmed_abk1900 crossref_primary_10_1159_000511557 crossref_primary_10_3389_fimmu_2023_1151632 crossref_primary_10_1038_s41467_021_23324_4 crossref_primary_10_1038_s41590_025_02192_w crossref_primary_10_1002_smll_202004905 crossref_primary_10_1126_sciimmunol_abc8122 crossref_primary_10_1002_cam4_7346 crossref_primary_10_1016_j_ccell_2022_01_002 crossref_primary_10_1016_j_immuni_2025_03_021 crossref_primary_10_1038_s41423_023_01118_6 crossref_primary_10_1073_pnas_2315989121 crossref_primary_10_3390_cancers14235940 crossref_primary_10_12998_wjcc_v10_i28_10193 crossref_primary_10_1038_s41590_020_0759_5 crossref_primary_10_1080_2162402X_2023_2212532 crossref_primary_10_1158_2326_6066_CIR_22_0406 crossref_primary_10_1073_pnas_2002806117 crossref_primary_10_1002_hep_31697 crossref_primary_10_3390_vaccines12010063 crossref_primary_10_1016_j_immuni_2024_07_003 crossref_primary_10_1158_2326_6066_CIR_22_0685 crossref_primary_10_1016_j_immuni_2025_04_030 crossref_primary_10_1016_j_neo_2022_100808 crossref_primary_10_3390_vaccines7040184 crossref_primary_10_3390_ijms221910828 crossref_primary_10_3389_fimmu_2021_838464 crossref_primary_10_1158_0008_5472_CAN_22_1744 crossref_primary_10_1007_s13402_025_01067_4 crossref_primary_10_1038_s41467_023_37379_y crossref_primary_10_3389_fimmu_2021_736670 crossref_primary_10_1038_s41586_019_1821_z crossref_primary_10_3390_cancers16081461 crossref_primary_10_1016_j_ejca_2023_05_019 crossref_primary_10_1016_j_drudis_2021_01_002 crossref_primary_10_1038_s41467_020_18570_x crossref_primary_10_1016_j_celrep_2024_114088 crossref_primary_10_1136_jitc_2022_006020 crossref_primary_10_3390_immuno2040041 crossref_primary_10_1016_j_jconrel_2019_10_041 crossref_primary_10_1126_sciimmunol_abj9123 crossref_primary_10_3389_fimmu_2024_1426418 crossref_primary_10_1016_j_it_2019_11_004 crossref_primary_10_1136_jitc_2023_008739 crossref_primary_10_1007_s00262_024_03793_4 crossref_primary_10_1002_advs_202510501 crossref_primary_10_1016_j_it_2019_11_008 crossref_primary_10_3389_froh_2022_902160 crossref_primary_10_1016_j_intimp_2023_111363 crossref_primary_10_1038_s41467_025_56029_z crossref_primary_10_1038_s41590_021_00965_7 crossref_primary_10_1038_s41422_020_0277_x crossref_primary_10_1172_jci_insight_190311 crossref_primary_10_1136_jitc_2021_003959 crossref_primary_10_3389_fonc_2023_1200387 crossref_primary_10_1158_0008_5472_CAN_23_3918 crossref_primary_10_1007_s00262_023_03447_x crossref_primary_10_1126_science_abl5447 crossref_primary_10_1038_s41416_025_03137_8 crossref_primary_10_1146_annurev_immunol_090222_110914 crossref_primary_10_1126_sciimmunol_adg3868 crossref_primary_10_1038_s41556_024_01351_9 crossref_primary_10_1016_j_xcrm_2024_101882 crossref_primary_10_1038_s41577_019_0223_7 crossref_primary_10_1016_j_ijrobp_2022_02_003 crossref_primary_10_1038_s41467_022_33768_x crossref_primary_10_1016_j_ccell_2021_07_007 crossref_primary_10_1089_vim_2021_0134 crossref_primary_10_1136_jitc_2021_002603 crossref_primary_10_1186_s12935_023_03158_4 crossref_primary_10_1038_s41392_022_01200_x crossref_primary_10_1158_1078_0432_CCR_22_1591 crossref_primary_10_1172_JCI152864 crossref_primary_10_3389_fonc_2024_1357801 crossref_primary_10_1016_j_jhep_2022_02_016 crossref_primary_10_1158_2326_6066_CIR_24_0089 crossref_primary_10_1038_s41590_022_01379_9 crossref_primary_10_1158_1078_0432_CCR_24_2983 crossref_primary_10_3390_ijms25179506 crossref_primary_10_1158_2326_6066_CIR_22_0699 crossref_primary_10_3389_fimmu_2025_1655176 crossref_primary_10_1007_s00262_020_02593_w crossref_primary_10_1080_2162402X_2023_2246319 crossref_primary_10_3389_fimmu_2024_1396719 crossref_primary_10_1038_s41590_022_01224_z crossref_primary_10_1371_journal_ppat_1008555 crossref_primary_10_3389_fimmu_2025_1603792 crossref_primary_10_1158_2326_6066_CIR_20_0384 crossref_primary_10_1016_j_neo_2024_101007 crossref_primary_10_1038_s41598_022_05474_7 crossref_primary_10_1038_s41590_024_01932_8 crossref_primary_10_1038_s41467_023_40745_5 crossref_primary_10_1016_j_celrep_2025_116316 crossref_primary_10_1002_advs_202400702 crossref_primary_10_1212_NXI_0000000000000627 crossref_primary_10_1016_j_immuni_2022_03_006 crossref_primary_10_4049_jimmunol_2100533 crossref_primary_10_1158_0008_5472_CAN_20_1674 crossref_primary_10_1016_j_cell_2024_03_037 crossref_primary_10_1172_JCI168318 crossref_primary_10_1111_1759_7714_14473 crossref_primary_10_1093_nargab_lqad018 crossref_primary_10_3389_fimmu_2020_587014 crossref_primary_10_1016_j_ccell_2022_02_004 crossref_primary_10_1016_j_jcyt_2021_08_007 crossref_primary_10_1038_s43018_025_00922_5 crossref_primary_10_1136_jitc_2023_008367 crossref_primary_10_3389_fimmu_2020_00364 crossref_primary_10_3389_fimmu_2023_1198551 crossref_primary_10_1126_sciimmunol_abq2630 crossref_primary_10_1016_j_heliyon_2024_e28156 crossref_primary_10_1097_MED_0000000000000488 crossref_primary_10_1038_s43018_022_00490_y crossref_primary_10_1038_s41568_024_00736_0 crossref_primary_10_1038_s41590_024_02044_z crossref_primary_10_3390_cancers13225856 crossref_primary_10_1016_j_immuni_2023_01_022 crossref_primary_10_1126_sciadv_adv6902 crossref_primary_10_1146_annurev_immunol_101721_064501 crossref_primary_10_1186_s12967_024_05456_5 crossref_primary_10_3389_fimmu_2020_00372 crossref_primary_10_1158_2326_6066_CIR_20_0586 crossref_primary_10_3389_fimmu_2023_1148061 crossref_primary_10_1136_jitc_2024_010735 crossref_primary_10_1136_jitc_2024_010736 crossref_primary_10_3390_cancers13184660 crossref_primary_10_1158_2326_6066_CIR_21_1050 crossref_primary_10_1126_sciimmunol_ade3369 crossref_primary_10_1016_j_immuni_2023_01_029 crossref_primary_10_1038_s41590_024_02020_7 crossref_primary_10_1158_1078_0432_CCR_20_2400 crossref_primary_10_1002_advs_202405749 crossref_primary_10_1038_s41467_023_37825_x crossref_primary_10_1038_s41596_025_01235_8 crossref_primary_10_1111_cas_15719 crossref_primary_10_1172_JCI163096 crossref_primary_10_4049_jimmunol_2000300 crossref_primary_10_1038_s41573_021_00155_y crossref_primary_10_1126_sciimmunol_abi8800 crossref_primary_10_1136_jitc_2022_004711 crossref_primary_10_3389_fonc_2022_943583 crossref_primary_10_1007_s00262_022_03319_w crossref_primary_10_1126_sciimmunol_add5976 crossref_primary_10_1186_s10020_025_01264_9 crossref_primary_10_1172_JCI144353 crossref_primary_10_1016_j_immuni_2024_06_017 crossref_primary_10_1016_j_it_2019_10_006 crossref_primary_10_1039_D5LC00062A crossref_primary_10_1038_s41423_023_01064_3 crossref_primary_10_3390_ijms26188788 crossref_primary_10_1007_s00262_022_03308_z crossref_primary_10_1126_science_abg5784 crossref_primary_10_1016_j_ccell_2024_06_009 crossref_primary_10_1016_j_immuni_2024_06_014 crossref_primary_10_1016_j_radmp_2025_09_005 crossref_primary_10_1007_s11538_025_01502_5 crossref_primary_10_3389_fimmu_2021_726492 crossref_primary_10_1172_JCI145459 crossref_primary_10_1016_j_immuni_2021_08_026 crossref_primary_10_1038_s41590_022_01219_w crossref_primary_10_1016_j_immuni_2022_02_005 crossref_primary_10_1038_s41467_025_60657_w crossref_primary_10_3389_fimmu_2020_00340 crossref_primary_10_1038_s41467_020_18256_4 crossref_primary_10_1038_s41467_023_41438_9 crossref_primary_10_3390_cancers14153796 crossref_primary_10_1016_j_jtho_2023_07_020 crossref_primary_10_1186_s12985_021_01712_y crossref_primary_10_1038_s41590_023_01685_w crossref_primary_10_1136_jitc_2024_010514 crossref_primary_10_1016_j_omton_2024_200827 crossref_primary_10_1038_s41423_020_0436_5 crossref_primary_10_62347_NCYZ7977 crossref_primary_10_3389_fonc_2020_00586 crossref_primary_10_37748_2686_9039_2025_6_3_7 crossref_primary_10_1016_j_ymthe_2023_07_012 crossref_primary_10_1097_HEP_0000000000000869 crossref_primary_10_1016_j_coi_2023_102283 crossref_primary_10_1016_j_celrep_2023_112876 crossref_primary_10_3390_pharmaceutics16050636 crossref_primary_10_1016_j_cell_2021_08_020 crossref_primary_10_1158_0008_5472_CAN_23_2455 crossref_primary_10_1016_j_canlet_2024_216858 crossref_primary_10_1016_j_jaccao_2023_08_003 crossref_primary_10_1016_j_cell_2024_02_022 crossref_primary_10_1080_2162402X_2021_1997385 crossref_primary_10_1038_s44321_023_00005_x crossref_primary_10_1080_2162402X_2024_2345859 crossref_primary_10_1016_j_intimp_2024_112571 crossref_primary_10_1097_CCO_0000000000000831 crossref_primary_10_3389_fimmu_2020_00577 crossref_primary_10_3390_cancers12082326 crossref_primary_10_1038_s41586_023_06299_8 crossref_primary_10_1038_s41590_021_00949_7 crossref_primary_10_3389_fcell_2021_674467 crossref_primary_10_1126_sciimmunol_adn9633 crossref_primary_10_1158_2326_6066_CIR_21_1083 crossref_primary_10_3390_cancers14041078 crossref_primary_10_1038_s41591_019_0522_3 crossref_primary_10_1016_j_immuni_2019_12_010 crossref_primary_10_1016_j_semcancer_2021_03_036 crossref_primary_10_1016_j_ccell_2022_03_006 crossref_primary_10_1073_pnas_2425992122 crossref_primary_10_1016_j_ymthe_2021_10_004 crossref_primary_10_1042_BST20221083 crossref_primary_10_1136_jitc_2023_008568 crossref_primary_10_1016_j_crmeth_2023_100643 crossref_primary_10_1038_s41586_024_07300_8 crossref_primary_10_1080_2162402X_2025_2521391 crossref_primary_10_1007_s10238_024_01394_0 crossref_primary_10_1016_j_cell_2021_07_015 crossref_primary_10_1182_bloodadvances_2020003080 crossref_primary_10_3389_fimmu_2021_660944 crossref_primary_10_1126_science_adk3248 crossref_primary_10_3389_fimmu_2023_1209588 crossref_primary_10_1038_s41467_024_46873_w crossref_primary_10_1016_j_tem_2024_05_010 crossref_primary_10_1182_blood_2023021680 crossref_primary_10_3389_fimmu_2020_589641 crossref_primary_10_1038_s41586_024_07135_3 crossref_primary_10_3390_ijms25105056 crossref_primary_10_1016_j_ccell_2022_03_012 crossref_primary_10_1038_s41467_024_49475_8 crossref_primary_10_1126_science_abb9847 crossref_primary_10_1016_j_micres_2024_127668 crossref_primary_10_1038_s41590_022_01326_8 crossref_primary_10_1128_JVI_00935_20 crossref_primary_10_3390_cancers11121832 crossref_primary_10_1038_s41467_025_60394_0 crossref_primary_10_1016_j_canlet_2022_216043 crossref_primary_10_1158_2326_6066_CIR_19_0855 crossref_primary_10_1038_s41598_024_63500_2 crossref_primary_10_1038_s41590_025_02228_1 crossref_primary_10_1038_s44319_024_00191_w crossref_primary_10_1007_s00262_021_03120_1 crossref_primary_10_1007_s00262_024_03699_1 crossref_primary_10_1007_s10238_022_00887_0 crossref_primary_10_3389_fimmu_2020_561083 crossref_primary_10_1007_s00262_024_03786_3 crossref_primary_10_1016_j_isci_2024_110754 crossref_primary_10_1016_j_intimp_2025_114843 crossref_primary_10_4049_jimmunol_2300334 crossref_primary_10_1038_d41586_019_03731_w crossref_primary_10_3390_cancers13122924 crossref_primary_10_1038_s41586_019_1836_5 crossref_primary_10_1111_cas_15546 crossref_primary_10_1038_s41423_019_0344_8 crossref_primary_10_3389_fimmu_2022_896242 crossref_primary_10_1016_j_trecan_2025_08_002 crossref_primary_10_1038_s41467_022_31504_z crossref_primary_10_1038_s41590_021_00958_6 crossref_primary_10_1111_cas_15311 crossref_primary_10_1016_j_canlet_2023_216350 crossref_primary_10_1007_s00262_025_04067_3 crossref_primary_10_1002_cac2_12178 crossref_primary_10_3389_fimmu_2025_1654000 crossref_primary_10_1038_s41388_024_03191_1 crossref_primary_10_1136_jitc_2021_003543 crossref_primary_10_3389_fimmu_2022_809872 crossref_primary_10_1002_adfm_202424205 crossref_primary_10_1038_s41551_023_01023_3 crossref_primary_10_1016_j_canlet_2024_216656 crossref_primary_10_1126_sciadv_adx5687 crossref_primary_10_1016_j_it_2020_03_003 crossref_primary_10_1038_s43018_022_00500_z crossref_primary_10_1111_imr_13203 crossref_primary_10_1111_cas_15541 crossref_primary_10_1186_s12951_025_03537_1 crossref_primary_10_1016_j_coviro_2020_10_003 crossref_primary_10_1016_j_immuni_2022_01_018 crossref_primary_10_1084_jem_20221920 crossref_primary_10_1136_jitc_2022_005413 crossref_primary_10_1016_j_ccell_2025_02_008 crossref_primary_10_1172_JCI161084 crossref_primary_10_1007_s10549_023_06956_6 crossref_primary_10_1186_s13148_025_01865_5 crossref_primary_10_1016_j_eururo_2021_01_017 crossref_primary_10_1007_s11010_024_05067_0 crossref_primary_10_1016_j_biopha_2021_112512 crossref_primary_10_1007_s00262_021_02921_8 crossref_primary_10_1038_s41467_024_53997_6 crossref_primary_10_1186_s40364_024_00684_9 crossref_primary_10_1002_jcla_24494 crossref_primary_10_1016_j_ccell_2022_04_005 crossref_primary_10_3390_ijms26157400 crossref_primary_10_1016_j_celrep_2025_116184 crossref_primary_10_1073_pnas_1903520116 crossref_primary_10_1016_j_ymthe_2020_07_018 crossref_primary_10_1038_s41571_020_00460_2 crossref_primary_10_1016_j_jhep_2023_08_024 crossref_primary_10_1158_1078_0432_CCR_23_0251 crossref_primary_10_3389_fimmu_2020_622509 crossref_primary_10_3389_fimmu_2024_1412731 crossref_primary_10_1093_intimm_dxaa049 crossref_primary_10_3389_fonc_2024_1381381 crossref_primary_10_1038_s41591_023_02345_0 crossref_primary_10_1038_s41698_023_00362_3 crossref_primary_10_1007_s00262_022_03182_9 crossref_primary_10_1186_s40164_024_00560_0 crossref_primary_10_1172_JCI165673 crossref_primary_10_1038_s41598_024_72826_w crossref_primary_10_3389_fimmu_2024_1362140 crossref_primary_10_1016_j_ccell_2025_03_036 crossref_primary_10_1016_j_omtm_2021_04_009 crossref_primary_10_3390_ijms22147481 crossref_primary_10_1038_s41467_023_41352_0 crossref_primary_10_1126_sciimmunol_adf2223 crossref_primary_10_1158_0008_5472_CAN_20_1818 crossref_primary_10_3390_cells10102563 crossref_primary_10_1136_jitc_2024_010581 crossref_primary_10_1146_annurev_immunol_070621_030155 crossref_primary_10_1038_s41423_020_0427_6 crossref_primary_10_1136_jitc_2022_005436 crossref_primary_10_1182_blood_2021012714 crossref_primary_10_1007_s00262_025_04102_3 crossref_primary_10_1186_s12964_025_02332_7 crossref_primary_10_1038_s41388_023_02670_1 crossref_primary_10_1182_bloodadvances_2020003857 crossref_primary_10_1038_s41467_024_54883_x crossref_primary_10_1186_s12865_020_00353_0 crossref_primary_10_1158_2326_6066_CIR_21_0265 crossref_primary_10_1002_ana_26198 crossref_primary_10_1038_s41586_024_07962_4 crossref_primary_10_1016_j_medj_2024_03_015 crossref_primary_10_1097_HEP_0000000000001439 crossref_primary_10_1371_journal_pone_0238380 crossref_primary_10_1038_s41590_024_02023_4 crossref_primary_10_1016_j_jconrel_2021_01_009 crossref_primary_10_3389_fimmu_2024_1424933 crossref_primary_10_1158_1078_0432_CCR_19_3323 crossref_primary_10_1182_bloodadvances_2023011287 crossref_primary_10_1136_jitc_2025_011905 crossref_primary_10_1136_jitc_2022_004574 crossref_primary_10_1016_j_intimp_2021_108093 crossref_primary_10_1136_jitc_2021_004034 crossref_primary_10_3389_fimmu_2020_613815 crossref_primary_10_1016_j_intimp_2025_114410 crossref_primary_10_3389_fimmu_2021_723609 crossref_primary_10_1038_s41590_025_02153_3 crossref_primary_10_1016_j_smim_2021_101485 crossref_primary_10_1016_j_smim_2019_101307 crossref_primary_10_3390_ijms252312550 crossref_primary_10_1002_1873_3468_70099 crossref_primary_10_1016_j_smim_2019_101306 crossref_primary_10_1002_mco2_437 crossref_primary_10_1016_j_ccell_2021_10_001 crossref_primary_10_1126_sciimmunol_abf6136 crossref_primary_10_1016_j_smim_2021_101480 crossref_primary_10_1007_s11538_025_01507_0 crossref_primary_10_1016_j_ccell_2021_10_008 crossref_primary_10_1093_intimm_dxac016 crossref_primary_10_2217_fon_2021_0288 crossref_primary_10_1016_j_ccell_2025_01_001 crossref_primary_10_1016_j_smim_2023_101848 crossref_primary_10_1158_1078_0432_CCR_23_0219 crossref_primary_10_1093_intimm_dxac013 crossref_primary_10_1038_s41467_021_25391_z crossref_primary_10_1126_scitranslmed_abn5029 crossref_primary_10_1007_s11538_024_01389_8 crossref_primary_10_3389_fimmu_2022_907172 crossref_primary_10_1111_bph_16313 crossref_primary_10_1007_s12032_023_02146_y crossref_primary_10_1172_JCI177460 crossref_primary_10_3389_fonc_2022_1029325 crossref_primary_10_1136_jitc_2021_003392 crossref_primary_10_1038_s41590_023_01645_4 crossref_primary_10_1016_j_ebiom_2022_104254 crossref_primary_10_1136_jitc_2024_010534 crossref_primary_10_1136_jitc_2025_011503 crossref_primary_10_1038_s41591_020_0944_y crossref_primary_10_1016_j_ccell_2022_05_004 crossref_primary_10_1007_s11882_025_01199_5 crossref_primary_10_3389_fimmu_2020_583382 crossref_primary_10_1002_advs_202503891 crossref_primary_10_1016_j_banm_2023_03_019 crossref_primary_10_1186_s12943_024_02175_9 crossref_primary_10_1038_s41587_021_00870_2 crossref_primary_10_1136_jitc_2024_009129 crossref_primary_10_3389_fimmu_2019_01595 crossref_primary_10_1093_intimm_dxac024 crossref_primary_10_3389_fimmu_2024_1477171 crossref_primary_10_1002_cam4_70087 crossref_primary_10_1002_advs_202310308 crossref_primary_10_1158_2326_6066_CIR_21_0690 crossref_primary_10_3390_v15061296 crossref_primary_10_1016_j_ccell_2025_01_008 crossref_primary_10_1084_jem_20230699 crossref_primary_10_1136_jitc_2024_009367 crossref_primary_10_1158_0008_5472_CAN_19_3807 crossref_primary_10_1002_cyto_a_24900 crossref_primary_10_1126_sciimmunol_adk2954 crossref_primary_10_1093_intimm_dxaa057 crossref_primary_10_1016_j_celrep_2021_109992 crossref_primary_10_1016_j_intimp_2023_110722 crossref_primary_10_1016_j_jpha_2024_100998 crossref_primary_10_1097_HEP_0000000000000553 crossref_primary_10_1038_s41392_024_01979_x crossref_primary_10_1038_s41467_023_35948_9 crossref_primary_10_1038_s41568_023_00615_0 crossref_primary_10_1038_s41586_023_06234_x crossref_primary_10_1172_JCI177492 crossref_primary_10_1016_j_immuni_2020_04_007 crossref_primary_10_3390_biomedicines10040805 crossref_primary_10_1038_s41467_024_52977_0 crossref_primary_10_1126_sciimmunol_adf8838 crossref_primary_10_1186_s12935_024_03521_z crossref_primary_10_1016_j_immuni_2020_04_014 crossref_primary_10_1038_s41467_021_27731_5 crossref_primary_10_1073_pnas_2025570118 crossref_primary_10_3389_fphar_2023_1327717 crossref_primary_10_1126_sciimmunol_add1591 crossref_primary_10_3389_fimmu_2023_1284937 crossref_primary_10_1016_j_ccell_2024_08_007 crossref_primary_10_1038_s41423_022_00939_1 crossref_primary_10_1038_s41568_019_0235_4 crossref_primary_10_1038_s42003_023_04812_3 crossref_primary_10_1097_ot9_0000000000000041 crossref_primary_10_1007_s10549_023_07111_x crossref_primary_10_3390_cells11071140 crossref_primary_10_1056_NEJMcibr2119477 crossref_primary_10_1097_HC9_0000000000000131 crossref_primary_10_1097_HEP_0000000000000320 crossref_primary_10_1038_s41435_024_00307_1 crossref_primary_10_1126_sciimmunol_abn8390 crossref_primary_10_1158_0008_5472_CAN_24_0830 crossref_primary_10_1002_aac2_12045 crossref_primary_10_1007_s10120_023_01456_4 crossref_primary_10_1172_JCI157649 crossref_primary_10_1016_j_bbcan_2022_188720 crossref_primary_10_1016_j_biomaterials_2025_123721 crossref_primary_10_1038_s41590_024_01860_7 crossref_primary_10_1016_j_micpath_2023_106089 crossref_primary_10_1016_j_cell_2022_03_033 crossref_primary_10_1084_jem_20241133 crossref_primary_10_1042_EBC20243001 crossref_primary_10_3389_fimmu_2025_1556982 crossref_primary_10_1158_2326_6066_CIR_24_0259 crossref_primary_10_3390_ijms20184624 crossref_primary_10_1038_s41581_025_00983_w crossref_primary_10_1186_s12916_023_03026_y crossref_primary_10_3390_ijms25031396 crossref_primary_10_1126_science_abe6474 crossref_primary_10_1016_j_ctarc_2021_100494 crossref_primary_10_1080_2162402X_2020_1810489 crossref_primary_10_1136_jitc_2022_006582 crossref_primary_10_1016_j_pharmr_2025_100042 crossref_primary_10_3389_fimmu_2020_584423 crossref_primary_10_1093_discim_kyac011 crossref_primary_10_1158_2326_6066_CIR_22_0116 crossref_primary_10_1038_s41586_024_07254_x crossref_primary_10_1084_jem_20241148 crossref_primary_10_4049_jimmunol_1900435 crossref_primary_10_1182_blood_2023019961 crossref_primary_10_3389_fimmu_2023_1214675 crossref_primary_10_3390_cancers13164139 crossref_primary_10_3389_fimmu_2023_1295218 crossref_primary_10_3389_fimmu_2025_1656925 crossref_primary_10_4049_jimmunol_2200681 crossref_primary_10_1186_s12943_024_02007_w crossref_primary_10_1038_s41423_020_00565_9 crossref_primary_10_1002_pros_23934 crossref_primary_10_1126_sciimmunol_abj3067 crossref_primary_10_3389_fimmu_2025_1601188 crossref_primary_10_1016_j_ijbiomac_2024_129352 crossref_primary_10_1186_s12876_025_03829_8 crossref_primary_10_3389_fimmu_2021_600829 crossref_primary_10_3389_fimmu_2023_1113858 crossref_primary_10_1016_j_jhep_2024_12_015 crossref_primary_10_1038_s41590_022_01210_5 crossref_primary_10_1016_j_ccell_2022_06_001 crossref_primary_10_1093_jimmun_vkae042 crossref_primary_10_1038_s41421_022_00415_0 crossref_primary_10_1093_intimm_dxac038 crossref_primary_10_1172_JCI163447 crossref_primary_10_1016_j_ymthe_2024_10_021 crossref_primary_10_3390_cells11111854 crossref_primary_10_1126_sciimmunol_abe4782 crossref_primary_10_1038_s41467_024_44787_1 crossref_primary_10_1038_s41467_025_58931_y crossref_primary_10_1158_2326_6066_CIR_23_0752 crossref_primary_10_1158_2767_9764_CRC_24_0310 crossref_primary_10_3389_fonc_2021_794183 crossref_primary_10_1016_j_biopha_2023_114646 crossref_primary_10_1016_j_tranon_2022_101559 crossref_primary_10_4103_jcrt_jcrt_41_24 crossref_primary_10_1007_s12672_025_02060_x crossref_primary_10_1038_s41590_019_0480_4 crossref_primary_10_1159_000526899 crossref_primary_10_1080_1061186X_2025_2479757 crossref_primary_10_1200_JCO_19_00709 crossref_primary_10_1038_s41467_024_44885_0 crossref_primary_10_3389_fimmu_2024_1476904 crossref_primary_10_1038_s41591_019_0596_y crossref_primary_10_1084_jem_20220686 crossref_primary_10_1136_jitc_2023_006896 crossref_primary_10_1016_j_omtn_2021_10_011 crossref_primary_10_1093_intimm_dxac043 crossref_primary_10_1136_jitc_2020_001544 crossref_primary_10_3389_fimmu_2024_1429302 crossref_primary_10_3389_fgene_2022_999966 crossref_primary_10_2147_OTT_S295102 crossref_primary_10_1158_0008_5472_CAN_24_3511 crossref_primary_10_3389_fonc_2023_1271255 crossref_primary_10_3390_ph14030200 crossref_primary_10_1093_intimm_dxac050 crossref_primary_10_3390_cells9112470 crossref_primary_10_1038_s41598_022_15136_3 crossref_primary_10_1016_j_intimp_2019_106012 crossref_primary_10_1084_jem_20220679 crossref_primary_10_1016_j_it_2022_01_006 crossref_primary_10_3389_fimmu_2020_00849 crossref_primary_10_1002_mco2_70132 crossref_primary_10_1371_journal_pone_0251731 crossref_primary_10_1016_j_trecan_2025_04_008 crossref_primary_10_1038_s41568_022_00503_z crossref_primary_10_1158_2159_8290_CD_20_0569 crossref_primary_10_1016_j_tig_2023_07_005 crossref_primary_10_1093_intimm_dxae032 crossref_primary_10_1038_s41467_024_53911_0 crossref_primary_10_1038_s41467_022_35281_7 crossref_primary_10_1038_s41467_024_54569_4 crossref_primary_10_3389_fonc_2021_799453 crossref_primary_10_1016_j_cell_2024_07_016 crossref_primary_10_1038_s41598_023_50062_y crossref_primary_10_1038_s43018_024_00734_z crossref_primary_10_3390_cancers14174192 crossref_primary_10_1016_j_ccell_2025_03_005 crossref_primary_10_1016_j_cell_2024_07_018 crossref_primary_10_1002_eji_202048761 crossref_primary_10_1016_j_celrep_2025_115733 crossref_primary_10_1016_j_jcyt_2022_07_009 crossref_primary_10_1038_s41467_024_53034_6 crossref_primary_10_1073_pnas_2102849118 crossref_primary_10_1136_gutjnl_2024_332837 crossref_primary_10_1016_j_jhep_2022_10_037 crossref_primary_10_1016_j_regen_2021_100042 crossref_primary_10_1136_jitc_2022_006533 crossref_primary_10_1136_jitc_2022_005443 crossref_primary_10_1016_j_ccell_2020_03_017 crossref_primary_10_1111_cas_16177 crossref_primary_10_1136_jitc_2024_010145 crossref_primary_10_1093_abt_tbac031 crossref_primary_10_1093_noajnl_vdaf006 crossref_primary_10_1158_2159_8290_CD_20_1677 crossref_primary_10_3389_fimmu_2023_1231836 crossref_primary_10_1002_eji_202048994 crossref_primary_10_1016_j_intimp_2024_113917 crossref_primary_10_3892_ol_2021_13171 crossref_primary_10_1182_blood_2019004547 crossref_primary_10_1038_s41568_023_00635_w crossref_primary_10_1016_j_immuni_2022_05_012 crossref_primary_10_1158_0008_5472_CAN_22_3864 crossref_primary_10_1073_pnas_2219086120 crossref_primary_10_1080_14737140_2023_2215435 crossref_primary_10_1084_jem_20211538 crossref_primary_10_1158_2159_8290_CD_23_1266 crossref_primary_10_1038_s12276_023_01105_x crossref_primary_10_1136_jitc_2020_001749 crossref_primary_10_1016_j_cell_2023_12_011 crossref_primary_10_1111_imm_13832 crossref_primary_10_1038_s43018_021_00247_z crossref_primary_10_1038_s41590_019_0403_4 crossref_primary_10_3390_cancers17071130 crossref_primary_10_1007_s00262_020_02792_5 crossref_primary_10_1158_1078_0432_CCR_20_3084 crossref_primary_10_3390_cells10092234 crossref_primary_10_1111_1759_7714_15058 crossref_primary_10_1126_science_aba1786 crossref_primary_10_1038_s41467_020_14442_6 crossref_primary_10_1080_13543784_2024_2360209 crossref_primary_10_1089_hum_2022_068 crossref_primary_10_1158_1078_0432_CCR_24_0177 crossref_primary_10_1002_advs_202204961 crossref_primary_10_1016_j_imlet_2022_04_003 crossref_primary_10_1136_jitc_2020_001501 crossref_primary_10_1161_ATVBAHA_123_320188 crossref_primary_10_3390_cancers15194808 crossref_primary_10_1158_2159_8290_CD_22_0869 crossref_primary_10_1080_2162402X_2020_1737369 crossref_primary_10_1158_2326_6066_CIR_21_0870 crossref_primary_10_3389_fimmu_2023_1166128 crossref_primary_10_3389_fimmu_2024_1435187 crossref_primary_10_1016_j_immuni_2024_09_017 crossref_primary_10_1038_s41467_023_42634_3 crossref_primary_10_1084_jem_20201730 crossref_primary_10_3389_fimmu_2022_1015585 crossref_primary_10_1016_j_celrep_2023_112940 crossref_primary_10_1158_2326_6066_CIR_22_0761 crossref_primary_10_3389_fimmu_2023_1204363 crossref_primary_10_1016_j_ccell_2023_02_002 crossref_primary_10_1038_s43856_024_00525_8 crossref_primary_10_1158_2159_8290_CD_22_1350 crossref_primary_10_1016_j_ebiom_2025_105822 crossref_primary_10_1126_science_adf1329 crossref_primary_10_3389_fimmu_2020_592328 crossref_primary_10_1016_j_imlet_2020_11_004 crossref_primary_10_1038_s41586_022_05192_0 crossref_primary_10_1016_j_jid_2020_03_943 crossref_primary_10_3389_fimmu_2020_592569 crossref_primary_10_1007_s00403_024_03758_8 crossref_primary_10_1016_j_immuni_2023_06_007 crossref_primary_10_1111_jcmm_17097 crossref_primary_10_1016_j_ccell_2025_06_013 crossref_primary_10_1111_cas_70055 crossref_primary_10_1158_2326_6066_CIR_22_0517 crossref_primary_10_1016_j_coi_2023_102323 crossref_primary_10_1158_1078_0432_CCR_21_0121 crossref_primary_10_1016_j_ccell_2025_06_012 crossref_primary_10_1016_j_jaccao_2022_09_005 crossref_primary_10_3389_fimmu_2022_1020422 crossref_primary_10_1038_s41467_022_31551_6 crossref_primary_10_1016_j_biopha_2024_117388 crossref_primary_10_1146_annurev_pathol_031920_093932 crossref_primary_10_1016_j_canlet_2022_215948 crossref_primary_10_1038_s41551_023_01083_5 crossref_primary_10_1186_s12929_024_01009_6 crossref_primary_10_1038_s41698_022_00273_9 crossref_primary_10_3390_medicina60030373 crossref_primary_10_1038_s41586_025_08994_0 crossref_primary_10_1084_jem_20210582 crossref_primary_10_1016_j_medj_2025_100804 crossref_primary_10_1038_s41467_020_19917_0 crossref_primary_10_1007_s00761_024_01577_0 crossref_primary_10_1016_j_copbio_2021_02_003 crossref_primary_10_1016_j_semcancer_2022_05_006 crossref_primary_10_1126_sciimmunol_abg7836 crossref_primary_10_1002_advs_202417432 crossref_primary_10_1016_j_ejcskn_2025_100737 crossref_primary_10_1016_j_celrep_2024_115023 crossref_primary_10_3389_fimmu_2024_1509874 crossref_primary_10_1016_j_immuni_2021_11_002 crossref_primary_10_1038_s41467_024_52098_8 crossref_primary_10_1186_s12964_024_01848_8 crossref_primary_10_3389_fimmu_2023_1267918 crossref_primary_10_3389_fimmu_2021_759217 crossref_primary_10_1136_jitc_2021_003614 crossref_primary_10_3389_fcell_2020_569219 crossref_primary_10_1038_s41587_023_01782_z crossref_primary_10_1016_j_immuni_2021_11_004 crossref_primary_10_1038_s41467_025_58510_1 crossref_primary_10_1038_s41577_023_00884_8 crossref_primary_10_1186_s13046_021_01872_3 crossref_primary_10_1186_s12935_023_03137_9 crossref_primary_10_1016_j_celrep_2024_114141 crossref_primary_10_1080_17474086_2024_2370552 crossref_primary_10_1200_EDBK_349799 crossref_primary_10_1172_JCI185838 crossref_primary_10_7554_eLife_62420 crossref_primary_10_1084_jem_20202512 crossref_primary_10_1172_JCI159579 crossref_primary_10_1002_advs_202304501 crossref_primary_10_1016_j_celrep_2025_115554 crossref_primary_10_3389_fimmu_2021_690499 crossref_primary_10_1186_s13045_023_01504_7 crossref_primary_10_1038_s43586_020_00008_9 crossref_primary_10_3389_fimmu_2021_643291 crossref_primary_10_1016_j_it_2021_10_012 crossref_primary_10_1136_jitc_2020_002231 crossref_primary_10_1126_sciadv_adv0885 crossref_primary_10_1186_s12885_021_08702_x crossref_primary_10_1016_j_ccell_2023_03_015 crossref_primary_10_1016_j_addr_2020_07_023 crossref_primary_10_1080_2162402X_2022_2034257 crossref_primary_10_1038_s41590_021_00979_1 crossref_primary_10_1126_sciimmunol_adh1306 crossref_primary_10_1016_j_immuni_2024_01_013 crossref_primary_10_1038_s41598_023_43122_w crossref_primary_10_4049_jimmunol_2200026 crossref_primary_10_1038_s41590_024_01999_3 crossref_primary_10_1002_advs_202413095 crossref_primary_10_1007_s10875_021_01109_0 crossref_primary_10_1126_scitranslmed_aay3575 crossref_primary_10_1158_1078_0432_CCR_21_0133 crossref_primary_10_1158_2326_6066_CIR_22_0524 crossref_primary_10_3389_fgene_2020_548719 crossref_primary_10_1016_j_banm_2021_01_018 crossref_primary_10_1158_2326_6066_CIR_22_0563 crossref_primary_10_1016_j_ebiom_2022_103840 crossref_primary_10_1038_s41577_019_0224_6 crossref_primary_10_4251_wjgo_v17_i8_109489 crossref_primary_10_1158_1078_0432_CCR_21_1252 crossref_primary_10_1038_s42003_023_04631_6 crossref_primary_10_1038_s41590_020_0725_2 crossref_primary_10_1093_bib_bbab575 crossref_primary_10_1158_2159_8290_CD_20_0603 crossref_primary_10_1158_2159_8290_CD_24_0991 crossref_primary_10_1016_j_immuni_2020_09_005 crossref_primary_10_1038_s41590_023_01529_7 crossref_primary_10_1016_j_it_2021_03_006 crossref_primary_10_1038_s43018_020_0066_y crossref_primary_10_1136_jitc_2022_005293 crossref_primary_10_3390_cancers15194850 crossref_primary_10_1126_scitranslmed_adr3718 crossref_primary_10_1126_sciimmunol_abh2383 crossref_primary_10_1172_JCI140752 crossref_primary_10_1016_j_immuni_2023_05_008 crossref_primary_10_1158_2159_8290_CD_22_1301 crossref_primary_10_1136_jitc_2020_001365 crossref_primary_10_1038_s41573_021_00345_8 crossref_primary_10_1016_j_ccell_2023_01_004 crossref_primary_10_1126_sciimmunol_abb9726 crossref_primary_10_1038_s41467_023_43462_1 crossref_primary_10_1126_scitranslmed_aay6863 crossref_primary_10_1146_annurev_immunol_101320_020220 crossref_primary_10_1016_j_bbcan_2024_189193 crossref_primary_10_1080_2162402X_2025_2502354 crossref_primary_10_1016_j_seminoncol_2025_152370 crossref_primary_10_3390_cancers17050880 crossref_primary_10_3390_v13101951 crossref_primary_10_1038_s42255_020_00280_9 crossref_primary_10_3390_ijms25179659 crossref_primary_10_1016_j_celrep_2025_115566 crossref_primary_10_1007_s00262_025_04086_0 crossref_primary_10_3389_fimmu_2021_738958 crossref_primary_10_1016_j_cell_2023_03_011 crossref_primary_10_1016_j_phrs_2019_104258 crossref_primary_10_1007_s10456_021_09792_8 crossref_primary_10_1016_j_biopha_2019_109199 crossref_primary_10_1136_jitc_2022_005079 crossref_primary_10_1007_s00262_021_02939_y crossref_primary_10_3389_fimmu_2023_1104771 crossref_primary_10_1038_s41586_023_06733_x crossref_primary_10_1002_imt2_231 crossref_primary_10_1136_jitc_2021_002723 crossref_primary_10_3390_cancers13184529 crossref_primary_10_1111_cas_15033 crossref_primary_10_3389_fimmu_2024_1449291 crossref_primary_10_1038_s41368_022_00160_w crossref_primary_10_1038_s41417_022_00495_w crossref_primary_10_3389_fimmu_2024_1302587 crossref_primary_10_1016_j_bbcan_2024_189162 crossref_primary_10_1038_s41540_024_00336_6 crossref_primary_10_7554_eLife_69015 crossref_primary_10_1038_s41467_021_27716_4 crossref_primary_10_1136_jitc_2025_012011 crossref_primary_10_1158_2326_6066_CIR_23_0547 crossref_primary_10_1016_j_smim_2020_101435 crossref_primary_10_1172_JCI195673 crossref_primary_10_3389_fimmu_2022_1074698 crossref_primary_10_1158_2326_6066_CIR_22_0333 crossref_primary_10_1038_s41590_021_00868_7 crossref_primary_10_1126_scitranslmed_abo4997 crossref_primary_10_1016_j_bbrc_2023_04_040 crossref_primary_10_1038_s41467_022_34175_y crossref_primary_10_1016_j_molcel_2021_03_045 crossref_primary_10_1016_j_clml_2021_05_006 crossref_primary_10_1016_j_jaut_2022_102861 crossref_primary_10_3389_fimmu_2024_1371559 crossref_primary_10_1038_s41590_020_0791_5 crossref_primary_10_1136_jitc_2023_007305 crossref_primary_10_1038_s41551_019_0512_2 crossref_primary_10_1084_jem_20201690 crossref_primary_10_3389_fonc_2022_1058894 crossref_primary_10_1016_j_gpb_2021_02_004 crossref_primary_10_1038_s41467_023_41357_9 crossref_primary_10_1038_s41577_021_00539_6 crossref_primary_10_1016_j_cmet_2022_03_013 crossref_primary_10_3389_fimmu_2022_985280 crossref_primary_10_1016_j_ccell_2023_02_020 crossref_primary_10_3390_cancers11050624 crossref_primary_10_1038_s41467_021_23356_w crossref_primary_10_1038_s41467_023_43427_4 crossref_primary_10_1016_j_coi_2021_02_001 crossref_primary_10_1016_j_coi_2024_102454 crossref_primary_10_2147_OTT_S539978 crossref_primary_10_1038_s12276_024_01301_3 crossref_primary_10_1016_j_immuni_2025_08_008 crossref_primary_10_1158_2326_6066_CIR_22_0927 crossref_primary_10_1007_s00432_025_06095_z crossref_primary_10_3390_hemato6020014 crossref_primary_10_3389_fonc_2023_1182301 crossref_primary_10_1016_j_scib_2025_03_054 crossref_primary_10_1038_s41423_020_00570_y crossref_primary_10_1038_s41467_025_58369_2 crossref_primary_10_1038_s41587_024_02226_y crossref_primary_10_1016_j_ccell_2023_12_008 crossref_primary_10_1136_jitc_2023_008001 crossref_primary_10_1016_j_omtm_2022_12_008 crossref_primary_10_1186_s12967_022_03798_6 crossref_primary_10_1038_s41598_025_14409_x crossref_primary_10_1002_ijc_32889 crossref_primary_10_1016_j_tem_2025_08_009 crossref_primary_10_1158_2159_8290_CD_21_0003 crossref_primary_10_3389_fimmu_2025_1533857 crossref_primary_10_1126_scitranslmed_abo7604 crossref_primary_10_1158_1078_0432_CCR_21_2372 crossref_primary_10_3389_fimmu_2021_777073 crossref_primary_10_1158_0008_5472_CAN_24_4383 crossref_primary_10_1158_2326_6066_CIR_22_0939 crossref_primary_10_1186_s12885_025_14261_2 crossref_primary_10_1016_j_semcancer_2024_07_001 crossref_primary_10_1038_s41598_023_42871_y crossref_primary_10_1016_j_nantod_2023_101833 crossref_primary_10_1016_j_immuni_2021_01_012 crossref_primary_10_1136_jitc_2023_008254 crossref_primary_10_1172_JCI157549 crossref_primary_10_1016_j_ccell_2023_12_013 crossref_primary_10_1016_j_tibs_2024_08_002 crossref_primary_10_1038_s41416_022_01725_6 crossref_primary_10_1126_scitranslmed_aay9013 crossref_primary_10_3390_ijms21197357 crossref_primary_10_1016_j_celrep_2025_116214 crossref_primary_10_1002_advs_202411053 crossref_primary_10_1158_2159_8290_CD_24_1409 crossref_primary_10_3389_fphar_2023_1146468 crossref_primary_10_1016_j_isci_2025_113147 crossref_primary_10_1038_s41467_021_26940_2 crossref_primary_10_1136_jitc_2021_003218 crossref_primary_10_3389_fimmu_2022_770132 crossref_primary_10_1038_s41467_021_21099_2 crossref_primary_10_1053_j_gastro_2022_06_045 crossref_primary_10_1097_CM9_0000000000002989 crossref_primary_10_1111_cts_12856 crossref_primary_10_1038_s41551_022_00852_y crossref_primary_10_1080_21645515_2022_2124785 crossref_primary_10_1158_2326_6066_CIR_20_0445 crossref_primary_10_1002_med_21727 crossref_primary_10_1038_s41467_022_35583_w crossref_primary_10_1186_s12964_023_01139_8 crossref_primary_10_1016_j_chembiol_2024_02_006 crossref_primary_10_2217_fon_2022_0061 crossref_primary_10_1136_jitc_2021_003464 crossref_primary_10_1038_s41591_021_01398_3 crossref_primary_10_1038_s41467_024_52252_2 crossref_primary_10_1038_s41556_022_01029_0 crossref_primary_10_1126_sciimmunol_abg0117 crossref_primary_10_1136_jitc_2024_008974 crossref_primary_10_3389_fgene_2022_972664 crossref_primary_10_1016_j_cell_2025_04_032 crossref_primary_10_1038_s41590_020_0793_3 crossref_primary_10_1016_j_esmoop_2025_105538 crossref_primary_10_1186_s43556_025_00267_6 crossref_primary_10_3390_cancers15153898 crossref_primary_10_1007_s00432_023_05499_z crossref_primary_10_1038_s41577_024_01091_9 crossref_primary_10_1084_jem_20240829 crossref_primary_10_3390_biomedicines10051181 crossref_primary_10_1136_jitc_2024_008970 crossref_primary_10_1182_blood_2020009309 crossref_primary_10_3389_fimmu_2023_1288027 crossref_primary_10_1136_jitc_2023_007180 crossref_primary_10_1016_j_xpro_2025_103703 crossref_primary_10_1038_s41467_021_23044_9 crossref_primary_10_3390_cancers16183135 crossref_primary_10_1038_s41568_019_0129_5 crossref_primary_10_3389_fimmu_2022_1022638 crossref_primary_10_1016_j_ccell_2023_03_009 crossref_primary_10_1016_j_jcis_2025_137468 crossref_primary_10_1080_2162402X_2022_2038403 crossref_primary_10_1136_jitc_2021_002347 crossref_primary_10_1136_jitc_2022_004803 crossref_primary_10_1136_jitc_2023_007114 crossref_primary_10_3390_cells9071727 crossref_primary_10_1007_s13402_022_00718_0 crossref_primary_10_1038_s41590_020_0760_z crossref_primary_10_1016_j_clim_2022_109078 crossref_primary_10_1172_jci_insight_183080 crossref_primary_10_1038_s41577_021_00563_6 crossref_primary_10_1016_j_apsb_2024_04_022 crossref_primary_10_1016_j_cell_2022_09_020 crossref_primary_10_1016_j_semcancer_2019_08_002 crossref_primary_10_1016_j_ccell_2023_11_010 crossref_primary_10_1111_imr_13356 crossref_primary_10_1038_s41577_021_00541_y crossref_primary_10_3390_cells12192404 crossref_primary_10_3389_fimmu_2022_866937 crossref_primary_10_1016_j_hoc_2024_05_009 crossref_primary_10_1038_s41556_024_01508_6 crossref_primary_10_1128_jvi_00225_23 crossref_primary_10_1016_j_cell_2025_05_013 crossref_primary_10_1126_sciimmunol_aba5962 crossref_primary_10_1172_JCI168465 crossref_primary_10_1182_bloodadvances_2022008562 crossref_primary_10_1016_j_cell_2023_02_021 crossref_primary_10_1016_j_immuni_2022_09_002 crossref_primary_10_1126_scitranslmed_abn1082 crossref_primary_10_1245_s10434_023_13935_0 crossref_primary_10_1146_annurev_cancerbio_070120_094725 crossref_primary_10_1172_JCI169314 crossref_primary_10_7554_eLife_82705 crossref_primary_10_1158_2326_6066_CIR_23_1011 crossref_primary_10_1126_sciimmunol_adg0878 crossref_primary_10_1038_s41577_021_00574_3 crossref_primary_10_1159_000542578 crossref_primary_10_3389_fimmu_2021_655697 crossref_primary_10_1016_j_celrep_2025_116258 crossref_primary_10_1007_s00262_024_03630_8 crossref_primary_10_1038_s43018_023_00566_3 crossref_primary_10_1097_TP_0000000000003851 crossref_primary_10_3389_fimmu_2022_884148 crossref_primary_10_1016_j_semcancer_2020_01_001 crossref_primary_10_3390_pathogens13121137 crossref_primary_10_1186_s40425_019_0814_7 crossref_primary_10_1016_j_immuni_2024_04_017 crossref_primary_10_1158_2159_8290_CD_23_0727 crossref_primary_10_1158_2326_6066_CIR_21_0058 crossref_primary_10_1136_gutjnl_2024_332371 crossref_primary_10_3389_fimmu_2024_1383110 crossref_primary_10_1038_s41590_023_01477_2 crossref_primary_10_1038_s41598_022_19256_8 crossref_primary_10_1016_j_ccell_2021_01_015 crossref_primary_10_1038_s41571_022_00689_z crossref_primary_10_1126_scitranslmed_abn5649 crossref_primary_10_1158_2326_6066_CIR_20_0401 crossref_primary_10_1186_s13073_020_00722_9 crossref_primary_10_3389_fimmu_2021_715234 crossref_primary_10_1038_s41467_023_40398_4 crossref_primary_10_3390_cancers15041093 crossref_primary_10_1016_j_immuni_2023_03_017 crossref_primary_10_1016_j_phrs_2019_104417 crossref_primary_10_1053_j_gastro_2020_03_074 crossref_primary_10_1073_pnas_1917298117 crossref_primary_10_1073_pnas_2019743117 crossref_primary_10_1136_jitc_2020_002273 crossref_primary_10_1126_sciimmunol_adt3537 crossref_primary_10_3390_ijms21186497 crossref_primary_10_1038_s41598_020_77941_y crossref_primary_10_1016_j_immuni_2024_04_006 crossref_primary_10_1158_2159_8290_CD_24_1232 crossref_primary_10_1038_s41590_024_01792_2 crossref_primary_10_1136_jitc_2021_003667 crossref_primary_10_1172_JCI166070 crossref_primary_10_1136_jitc_2025_012089 crossref_primary_10_3389_fimmu_2020_01350 crossref_primary_10_1186_s12916_025_04001_5 crossref_primary_10_1186_s12943_024_02023_w crossref_primary_10_3389_fimmu_2025_1600792 crossref_primary_10_1016_j_ccell_2023_04_010 crossref_primary_10_1016_j_cell_2020_11_009 crossref_primary_10_1038_s41467_022_33834_4 crossref_primary_10_3390_ijms21197139 crossref_primary_10_1016_j_ccell_2023_04_011 crossref_primary_10_3389_fimmu_2023_1280986 crossref_primary_10_1038_s41551_024_01303_6 crossref_primary_10_1016_j_ebiom_2023_104614 crossref_primary_10_1038_s41587_023_02060_8 crossref_primary_10_3389_fimmu_2023_1152035 crossref_primary_10_1038_s41586_022_04682_5 crossref_primary_10_1038_s43018_022_00334_9 crossref_primary_10_1016_j_prp_2025_156163 crossref_primary_10_1038_s41586_023_06575_7 crossref_primary_10_4049_jimmunol_2001348 crossref_primary_10_1158_1078_0432_CCR_19_3231 crossref_primary_10_1016_j_ccell_2022_12_007 crossref_primary_10_1038_s41375_023_01808_0 crossref_primary_10_1038_s41467_022_32567_8 crossref_primary_10_3389_fimmu_2022_809414 crossref_primary_10_1016_j_immuni_2025_06_001 crossref_primary_10_3389_fimmu_2021_706150 crossref_primary_10_3390_ijms26125911 crossref_primary_10_1038_s41568_023_00560_y crossref_primary_10_1038_s41590_025_02219_2 crossref_primary_10_4049_jimmunol_2300785 crossref_primary_10_1136_jitc_2024_009449 crossref_primary_10_1038_s41551_021_00820_y crossref_primary_10_3389_fimmu_2023_1125905 crossref_primary_10_1002_ijc_34669 crossref_primary_10_1172_JCI129466 crossref_primary_10_1158_2326_6066_CIR_21_0129 crossref_primary_10_3389_fimmu_2024_1475062 crossref_primary_10_1136_jitc_2024_009440 crossref_primary_10_1186_s13059_022_02651_9 crossref_primary_10_1016_j_it_2023_02_006 crossref_primary_10_1038_s41467_022_33780_1 crossref_primary_10_1084_jem_20241417 crossref_primary_10_1056_NEJMra2028358 crossref_primary_10_1007_s00432_022_04326_1 crossref_primary_10_1016_j_molcel_2023_02_026 crossref_primary_10_1186_s13048_023_01313_z crossref_primary_10_3390_cancers12071941 crossref_primary_10_1016_j_banm_2022_07_017 crossref_primary_10_1126_sciimmunol_adr0782 crossref_primary_10_1172_JCI164258 crossref_primary_10_1002_jev2_12357 crossref_primary_10_1016_j_immuni_2019_09_018 crossref_primary_10_1038_s41571_024_00984_x crossref_primary_10_1186_s12964_025_02146_7 crossref_primary_10_1186_s40164_024_00506_6 crossref_primary_10_1007_s11538_023_01207_7 crossref_primary_10_1159_000543998 crossref_primary_10_1182_blood_2023022823 crossref_primary_10_1002_cam4_6802 crossref_primary_10_1158_2326_6066_CIR_21_0137 crossref_primary_10_1007_s12032_022_01654_7 crossref_primary_10_1038_s41467_024_46118_w crossref_primary_10_1038_s41590_024_01828_7 crossref_primary_10_1007_s40257_024_00858_z crossref_primary_10_1136_jitc_2020_000978 crossref_primary_10_3389_fimmu_2025_1562248 crossref_primary_10_1097_IN9_0000000000000012 crossref_primary_10_1016_j_ccell_2021_02_015 crossref_primary_10_1084_jem_20240776 crossref_primary_10_1016_j_ccell_2021_02_013 crossref_primary_10_1136_jitc_2021_003293 crossref_primary_10_1038_s41467_024_53262_w crossref_primary_10_1016_j_cell_2020_09_048 crossref_primary_10_1016_j_semcancer_2022_08_009 crossref_primary_10_1038_s41467_023_40959_7 crossref_primary_10_1038_s41586_020_2422_6 crossref_primary_10_3389_fimmu_2024_1304183 crossref_primary_10_1136_jitc_2020_000967 crossref_primary_10_1158_2326_6066_CIR_19_0877 crossref_primary_10_3389_fonc_2021_793808 crossref_primary_10_1126_sciimmunol_abh1873 crossref_primary_10_1186_s13059_024_03435_z crossref_primary_10_1038_s41467_021_24591_x crossref_primary_10_1038_s41467_024_46195_x crossref_primary_10_1016_j_ccell_2022_11_002 crossref_primary_10_1002_advs_202101672 crossref_primary_10_1002_ctm2_1817 crossref_primary_10_1038_s41416_025_02977_8 crossref_primary_10_1038_s41591_024_03271_5 crossref_primary_10_1038_s43018_021_00292_8 crossref_primary_10_2217_imt_2020_0178 crossref_primary_10_1002_cti2_1168 crossref_primary_10_1016_j_actbio_2022_06_041 crossref_primary_10_3389_fendo_2020_624122 crossref_primary_10_1136_jitc_2024_009011 crossref_primary_10_3390_ijms251910263 crossref_primary_10_1093_carcin_bgab035 crossref_primary_10_3389_fphar_2021_715721 crossref_primary_10_1007_s00262_025_04027_x crossref_primary_10_1016_j_immuni_2023_09_005 crossref_primary_10_1016_j_immuni_2022_10_020 crossref_primary_10_1007_s00262_024_03810_6 crossref_primary_10_1007_s11904_022_00626_w crossref_primary_10_1084_jem_20220745 crossref_primary_10_1111_imm_13575 crossref_primary_10_1016_j_celrep_2024_114401 crossref_primary_10_1038_s41591_021_01244_6 crossref_primary_10_4049_jimmunol_2400234 crossref_primary_10_3389_fcell_2020_00017 crossref_primary_10_3389_fimmu_2020_600886 crossref_primary_10_1136_bmjonc_2024_000328 crossref_primary_10_1016_j_immuni_2021_05_003 crossref_primary_10_4103_jcrt_jcrt_2453_23 crossref_primary_10_3389_fvets_2021_772932 crossref_primary_10_3389_fonc_2021_653625 crossref_primary_10_1002_ctm2_774 crossref_primary_10_1136_jitc_2020_000705 crossref_primary_10_1038_s41590_021_01060_7 crossref_primary_10_3390_jcm10050991 crossref_primary_10_1038_s41598_024_62871_w crossref_primary_10_1093_jimmun_vkaf050 crossref_primary_10_1126_sciimmunol_adp7302 crossref_primary_10_1038_s41467_021_27179_7 crossref_primary_10_1158_1078_0432_CCR_23_1444 crossref_primary_10_1038_s41467_024_45084_7 crossref_primary_10_1084_jem_20241433 crossref_primary_10_3390_cancers13164245 crossref_primary_10_1007_s12672_024_01410_5 crossref_primary_10_1172_JCI180983 crossref_primary_10_1084_jem_20230542 crossref_primary_10_1158_2326_6066_CIR_20_0800 crossref_primary_10_1126_scitranslmed_add1868 crossref_primary_10_1016_j_cmet_2020_10_013 crossref_primary_10_3389_fimmu_2023_1334597 crossref_primary_10_1097_IN9_0000000000000059 crossref_primary_10_1111_imr_13057 crossref_primary_10_1038_s41526_022_00217_4 crossref_primary_10_3390_cancers16111950 crossref_primary_10_3389_fimmu_2024_1370907 crossref_primary_10_3390_cancers13235911 crossref_primary_10_1126_sciimmunol_abd5778 crossref_primary_10_1016_j_immuni_2021_06_007 crossref_primary_10_1136_jitc_2022_005509 crossref_primary_10_1016_j_immuni_2023_09_004 crossref_primary_10_1016_j_omto_2023_100749 crossref_primary_10_1136_jitc_2024_010685 crossref_primary_10_1016_j_immuni_2021_06_013 crossref_primary_10_1016_j_ccell_2023_06_008 crossref_primary_10_1186_s13046_024_03207_4 crossref_primary_10_3389_fimmu_2024_1347900 crossref_primary_10_1038_s41591_021_01233_9 crossref_primary_10_1002_mco2_111 crossref_primary_10_1172_JCI192731 crossref_primary_10_1016_j_xcrm_2025_102210 crossref_primary_10_1126_sciimmunol_abf4034 crossref_primary_10_1016_j_celrep_2024_114632 crossref_primary_10_1038_s41556_024_01358_2 crossref_primary_10_1084_jem_20200920 crossref_primary_10_1038_s41591_020_1006_1 crossref_primary_10_3390_cancers13061263 crossref_primary_10_1042_EBC20220247 crossref_primary_10_1126_sciimmunol_ads6295 crossref_primary_10_3892_ijo_2025_5762 crossref_primary_10_1038_s41467_020_19192_z crossref_primary_10_1007_s13365_021_01028_1 crossref_primary_10_1038_s41586_024_08257_4 crossref_primary_10_1172_jci_insight_174600 crossref_primary_10_1158_2326_6066_CIR_21_0515 crossref_primary_10_1182_blood_2022016597 crossref_primary_10_1016_j_pharmthera_2021_107923 crossref_primary_10_1038_s41586_023_06568_6 crossref_primary_10_3389_fimmu_2022_982026 crossref_primary_10_1016_j_ccell_2021_04_004 crossref_primary_10_1038_s41467_025_59620_6 crossref_primary_10_1097_COH_0000000000000957 crossref_primary_10_4049_jimmunol_2200317 crossref_primary_10_1080_10428194_2022_2081326 crossref_primary_10_1038_s41568_024_00699_2 crossref_primary_10_1038_s41590_024_01896_9 crossref_primary_10_2217_bmm_2023_0202 crossref_primary_10_3389_fimmu_2022_996663 crossref_primary_10_1186_s12885_024_12994_0 crossref_primary_10_3389_fimmu_2021_670391 crossref_primary_10_20900_immunometab20210007 crossref_primary_10_3389_fonc_2022_1018767 crossref_primary_10_1172_JCI160025 crossref_primary_10_4049_jimmunol_2200320 crossref_primary_10_3389_fimmu_2025_1486329 crossref_primary_10_1080_14728222_2021_1937123 crossref_primary_10_1136_jitc_2025_011652 crossref_primary_10_1016_j_it_2019_06_002 crossref_primary_10_1073_pnas_2304319120 crossref_primary_10_1111_cas_15167 crossref_primary_10_1007_s00262_024_03823_1 crossref_primary_10_1111_cas_15161 crossref_primary_10_1016_j_ccell_2023_08_013 crossref_primary_10_1016_j_it_2020_06_002 crossref_primary_10_1136_jitc_2025_011657 crossref_primary_10_1038_s41586_023_06217_y crossref_primary_10_1038_s41577_019_0221_9 crossref_primary_10_1158_2159_8290_CD_19_1409 crossref_primary_10_3389_fimmu_2021_668045 crossref_primary_10_1136_jitc_2022_005398 crossref_primary_10_1186_s12943_024_02104_w crossref_primary_10_1371_journal_pone_0332406 crossref_primary_10_7717_peerj_16825 crossref_primary_10_1126_science_abf9419 crossref_primary_10_1136_jitc_2023_007614 crossref_primary_10_1158_2326_6066_CIR_21_0536 crossref_primary_10_3389_fimmu_2023_1117092 crossref_primary_10_3390_pharmaceutics14102234 crossref_primary_10_1016_j_ejca_2022_07_004 crossref_primary_10_1136_jitc_2024_011162 crossref_primary_10_1038_s41590_021_00940_2 crossref_primary_10_1126_sciimmunol_adi3487 crossref_primary_10_1158_2326_6066_CIR_19_0228 crossref_primary_10_1016_j_cell_2019_07_019 crossref_primary_10_1093_discim_kyad006 crossref_primary_10_3390_cells10071651 crossref_primary_10_1038_s41586_021_03626_9 crossref_primary_10_1038_s41392_022_01270_x crossref_primary_10_1038_s41698_023_00441_5 crossref_primary_10_1038_s41590_020_0668_7 crossref_primary_10_1016_j_it_2020_09_003 crossref_primary_10_1038_s41467_025_57819_1 crossref_primary_10_1038_s41590_021_00975_5 crossref_primary_10_1186_s12935_023_02948_0 crossref_primary_10_1038_s41590_021_00964_8 crossref_primary_10_1016_j_ccell_2021_04_016 crossref_primary_10_1038_s41586_024_08466_x crossref_primary_10_1038_s43018_023_00612_0 crossref_primary_10_1136_jitc_2021_002809 crossref_primary_10_1136_jitc_2025_011638 crossref_primary_10_1172_JCI134622 crossref_primary_10_1172_JCI143729 crossref_primary_10_1038_s41590_020_00834_9 crossref_primary_10_3390_biomedicines13040930 crossref_primary_10_1084_jem_20201811 crossref_primary_10_3389_fimmu_2021_787574 crossref_primary_10_1080_2162402X_2025_2540504 crossref_primary_10_1155_2020_7375947 crossref_primary_10_1080_08830185_2024_2401352 crossref_primary_10_1093_jimmun_vkaf216 crossref_primary_10_1038_s41591_023_02415_3 crossref_primary_10_1038_s41590_022_01409_6 crossref_primary_10_1016_j_cmet_2022_11_005 crossref_primary_10_1038_s41590_020_00810_3 crossref_primary_10_1158_2326_6066_CIR_22_0040 crossref_primary_10_1371_journal_pbio_3002943 crossref_primary_10_1002_JLB_5MR1120_778R crossref_primary_10_1038_s41467_025_57465_7 crossref_primary_10_1097_CAD_0000000000001480 crossref_primary_10_1038_s41591_020_1061_7 crossref_primary_10_3389_fbioe_2023_1065773 crossref_primary_10_1097_JS9_0000000000001939 crossref_primary_10_1158_1078_0432_CCR_21_0206 crossref_primary_10_1038_s41590_025_02232_5 crossref_primary_10_3389_fimmu_2021_662565 crossref_primary_10_1080_08820139_2022_2144347 crossref_primary_10_1007_s13402_025_01040_1 crossref_primary_10_3389_fimmu_2022_869768 crossref_primary_10_1038_s41467_025_59784_1 crossref_primary_10_1093_bjr_tqae100 crossref_primary_10_1016_j_ymthe_2024_04_004 crossref_primary_10_1038_s41551_023_01085_3 crossref_primary_10_1038_s41587_023_01940_3 crossref_primary_10_1038_s41556_022_01024_5 crossref_primary_10_1038_s41590_024_01961_3 crossref_primary_10_1126_sciimmunol_adf4726 crossref_primary_10_1126_sciimmunol_adf4968 crossref_primary_10_1002_ctm2_133 crossref_primary_10_1016_j_neo_2024_101072 crossref_primary_10_1080_2162402X_2024_2344905 crossref_primary_10_3390_ijms232113241 crossref_primary_10_1007_s10120_025_01640_8 crossref_primary_10_1038_s41590_020_0733_2 crossref_primary_10_1136_jitc_2023_006714 crossref_primary_10_1146_annurev_cancerbio_030518_055817 crossref_primary_10_1038_s41556_025_01753_3 crossref_primary_10_1038_s41416_025_02962_1 crossref_primary_10_1158_2159_8290_CD_20_1554 crossref_primary_10_3389_fimmu_2023_1164284 crossref_primary_10_1093_jimmun_vkaf210 crossref_primary_10_1126_sciimmunol_adi7418 crossref_primary_10_1016_j_tcb_2023_04_001 crossref_primary_10_1038_s41598_025_87344_6 crossref_primary_10_1371_journal_ppat_1009132 crossref_primary_10_1038_s41467_025_56270_6 crossref_primary_10_1038_s41575_024_01015_x crossref_primary_10_1007_s13402_023_00908_4 crossref_primary_10_1016_j_ccell_2023_09_011 crossref_primary_10_1016_j_isci_2025_112897 crossref_primary_10_1016_j_tibs_2023_03_004 crossref_primary_10_3390_onco5030032 crossref_primary_10_1073_pnas_2221985120 crossref_primary_10_1136_jitc_2020_001631 crossref_primary_10_3389_fimmu_2021_660361 crossref_primary_10_1111_imcb_12498 crossref_primary_10_3390_jcm11206021 crossref_primary_10_1016_j_ccell_2023_08_001 crossref_primary_10_3389_fimmu_2020_586907 crossref_primary_10_3390_ijms24054786 crossref_primary_10_1158_2159_8290_CD_21_1077 crossref_primary_10_1136_jitc_2020_000772 crossref_primary_10_3389_fimmu_2019_03039 crossref_primary_10_1016_j_jaut_2020_102546 crossref_primary_10_1038_s41586_021_03704_y crossref_primary_10_1002_eji_202149486 crossref_primary_10_1136_jitc_2024_011377 crossref_primary_10_3389_fonc_2021_544339 crossref_primary_10_1093_oxfimm_iqad006 crossref_primary_10_1007_s40259_024_00700_2 crossref_primary_10_1097_MED_0000000000000735 crossref_primary_10_1038_s41568_024_00740_4 crossref_primary_10_7554_eLife_52539 crossref_primary_10_1186_s12896_019_0559_x crossref_primary_10_1016_j_apsb_2022_05_006 crossref_primary_10_1073_pnas_2315419121 crossref_primary_10_3389_fimmu_2023_1172913
Cites_doi	10.1002/9780471729259.mc15a01s8 10.1038/nmeth.2688 10.1038/s41467-017-01062-w 10.1038/nature19330 10.1158/2326-6066.CIR-17-0249 10.1172/JCI46102 10.1073/pnas.0506580102 10.4049/jimmunol.1101205 10.1016/j.immuni.2012.08.021 10.1038/nature13954 10.1126/science.1229620 10.1073/pnas.1232420100 10.1126/sciimmunol.aai8593 10.1016/j.immuni.2015.01.006 10.1084/jem.20180684 10.1073/pnas.1620498114 10.1038/ni.3543 10.1016/j.cell.2015.08.012 10.1038/nature19317 10.1182/blood-2008-12-195792 10.1038/nature04444 10.1084/jem.187.9.1383 10.1016/j.immuni.2016.07.021 10.1056/NEJMoa1406498 10.1073/pnas.0801497105 10.1084/jem.20100643 10.1038/nbt.3192 10.1038/ni.1679 10.1084/jem.188.12.2205 10.1126/science.aaf2807 10.1182/blood-2017-03-770719 10.1126/science.283.5403.857 10.1038/ni.2035 10.1140/epjb/e2013-40829-0 10.1016/j.cell.2017.07.024 10.1126/science.aae0491 10.1111/pcmr.12220 10.1073/pnas.1720447115 10.1038/ng.3646 10.1016/j.cell.2016.08.052 10.1038/362758a0 10.1186/s12859-016-1176-5 10.1016/j.immuni.2016.07.011 10.1038/s41591-018-0057-z 10.1016/j.immuni.2007.09.006 10.1016/j.cell.2018.10.038 10.1016/j.ccell.2018.03.012 10.1038/nature22367 10.4049/jimmunol.162.11.6442
ContentType	Journal Article
Copyright	The Author(s), under exclusive licence to Springer Nature America, Inc. 2019 2019© The Author(s), under exclusive licence to Springer Nature America, Inc. 2019 The Author(s), under exclusive licence to Springer Nature America, Inc. 2019.
Copyright_xml	– notice: The Author(s), under exclusive licence to Springer Nature America, Inc. 2019 – notice: 2019© The Author(s), under exclusive licence to Springer Nature America, Inc. 2019 – notice: The Author(s), under exclusive licence to Springer Nature America, Inc. 2019.
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7QR 7T5 7TK 7TM 7U9 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7N M7P P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS RC3 7X8 5PM
DOI	10.1038/s41590-019-0312-6
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Immunology Abstracts Neurosciences Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database (ProQuest) Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles)
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection Chemoreception Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Public Health ProQuest SciTech Collection ProQuest Medical Library Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	ProQuest Central Student MEDLINE - Academic MEDLINE ProQuest Central Student
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine Biology
EISSN	1529-2916
EndPage	336
ExternalDocumentID	PMC6673650 30778252 10_1038_s41590_019_0312_6
Genre	Research Support, Non-U.S. Gov't Journal Article
GrantInformation_xml	– fundername: NCI NIH HHS grantid: T32 CA207021 – fundername: NIAID NIH HHS grantid: K23 AI130408
GroupedDBID	--- .55 0R~ 123 29M 2FS 36B 39C 3V. 4.4 53G 5BI 5RE 70F 7X7 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8R4 8R5 AAEEF AAHBH AARCD AAYZH AAZLF ABAWZ ABDBF ABJNI ABLJU ABNNU ABOCM ABUWG ACBWK ACGFS ACIWK ACPRK ACRPL ACUHS ADBBV ADNMO AENEX AEUYN AFBBN AFKRA AFRAH AFSHS AGAYW AGGDT AGHTU AHBCP AHMBA AHOSX AHSBF AIBTJ AIYXT ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS ARMCB ASPBG AVWKF AXYYD AZFZN BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI CCPQU CS3 DB5 DU5 EAD EAP EAS EBS EE. EJD EMB EMK EMOBN ESX EXGXG F5P FEDTE FQGFK FSGXE FYUFA HCIFZ HMCUK HVGLF HZ~ IAO IHR INH INR ISR ITC L-9 LK8 M1P M7P N9A NNMJJ O9- ODYON P2P PQQKQ PROAC PSQYO Q2X RNT RNTTT SHXYY SIXXV SNYQT SOJ SV3 TAOOD TBHMF TDRGL TSG TUS UKHRP WH7 X7M Y6R ZXP AAYXX ABFSG ACSTC AEZWR AFANA AFFHD AFHIU AGSTI AHWEU AIXLP ALPWD ATHPR CITATION PHGZM PHGZT PJZUB PPXIY PQGLB AGQPQ CGR CUY CVF ECM EIF NFIDA NPM 7QP 7QR 7T5 7TK 7TM 7U9 7XB 8FD 8FK AZQEC DWQXO FR3 GNUQQ H94 K9. M7N P64 PKEHL PQEST PQUKI PRINS RC3 7X8 PUEGO 5PM
ID	FETCH-LOGICAL-c498t-5e33840fab13a3a6197f7097cda2c09ac8af4b6e23ff151c209aad4177e6ea203
IEDL.DBID	M7P
ISICitedReferencesCount	1467
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000458893600017&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1529-2908 1529-2916
IngestDate	Tue Nov 04 02:05:54 EST 2025 Thu Oct 02 05:47:20 EDT 2025 Sun Nov 30 03:55:08 EST 2025 Tue Oct 07 05:34:48 EDT 2025 Mon Jul 21 06:01:24 EDT 2025 Sat Nov 29 02:12:21 EST 2025 Tue Nov 18 22:27:33 EST 2025 Fri Feb 21 02:38:59 EST 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	3
Language	English
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c498t-5e33840fab13a3a6197f7097cda2c09ac8af4b6e23ff151c209aad4177e6ea203
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 J.J.I., J.L.C., A.P., S.M., D.E.C., S.A.W. and F.D.B. performed mouse experiments and/or data analysis. M.D.Z., R.T.M. and F.S.H. provided critical reagents. A.L., K.F., G.S.N., M.M., E.G., G.K.G., F.S.H. and S.J.R. collected human samples and data. B.C.M., D.R.S. and W.N.H. wrote the manuscript. All authors reviewed and edited the manuscript. B.C.M., D.R.S. and W.N.H. conceived the study. B.C.M., D.R.S., A.H.S. and W.N.H. designed the experiments. B.C.M., D.R.S., R.A.A., K.B., Y.V.V., M.W.L., K.B.Y., J.R.K. Author contributions
ORCID	0000-0001-5400-1306 0000-0002-5017-774X 0000-0001-7871-3762 0000-0002-4071-4986 0000-0002-0947-8284 0000-0001-5931-4184
OpenAccessLink	https://www.ncbi.nlm.nih.gov/pmc/articles/6673650
PMID	30778252
PQID	2183741346
PQPubID	45782
PageCount	11
ParticipantIDs	pubmedcentral_primary_oai_pubmedcentral_nih_gov_6673650 proquest_miscellaneous_2183650912 proquest_journals_2475058418 proquest_journals_2183741346 pubmed_primary_30778252 crossref_citationtrail_10_1038_s41590_019_0312_6 crossref_primary_10_1038_s41590_019_0312_6 springer_journals_10_1038_s41590_019_0312_6
PublicationCentury	2000
PublicationDate	2019-03-01
PublicationDateYYYYMMDD	2019-03-01
PublicationDate_xml	– month: 03 year: 2019 text: 2019-03-01 day: 01
PublicationDecade	2010
PublicationPlace	New York
PublicationPlace_xml	– name: New York – name: United States
PublicationTitle	Nature immunology
PublicationTitleAbbrev	Nat Immunol
PublicationTitleAlternate	Nat Immunol
PublicationYear	2019
Publisher	Nature Publishing Group US Nature Publishing Group
Publisher_xml	– name: Nature Publishing Group US – name: Nature Publishing Group
References	Sakuishi (CR20) 2010; 207 Horton, Williams, Cabanov, Spranger, Gajewski (CR35) 2018; 6 Waltman, van Eck (CR45) 2013; 86 Wherry (CR11) 2007; 27 Zajac (CR3) 1998; 188 Blackburn, Shin, Freeman, Wherry (CR18) 2008; 105 Wei (CR24) 2017; 170 Mognol (CR10) 2017; 114 Jenkins (CR27) 2014; 27 Satija, Farrell, Gennert, Schier, Regev (CR44) 2015; 33 Im (CR14) 2016; 537 Thommen, Schumacher (CR1) 2018; 33 Welsh, Seedhom (CR41) 2008; 8 Subramanian (CR43) 2005; 102 Ho (CR34) 2015; 162 Schmitz (CR36) 1999; 283 Leong (CR16) 2016; 17 Pauken (CR33) 2016; 354 Blackburn (CR25) 2009; 10 Woolf (CR30) 2003; 100 Philip (CR23) 2017; 545 Singer (CR22) 2016; 166 Brummelman (CR37) 2018; 215 Ahmadzadeh (CR2) 2009; 114 He (CR15) 2016; 537 Doering (CR9) 2012; 37 Ferreira (CR29) 1999; 162 Sade-Feldman (CR40) 2017; 8 Thommen (CR39) 2018; 24 Yates, Bi, Haining, Cantor, Kim (CR42) 2018; 115 Tumeh (CR32) 2014; 515 Carey (CR49) 2017; 130 Schietinger (CR21) 2016; 45 Wu (CR17) 2016; 1 Paley (CR12) 2012; 338 Baitsch (CR19) 2011; 121 Buenrostro, Giresi, Zaba, Chang, Greenleaf (CR48) 2013; 10 Wang (CR28) 2011; 187 Martinez (CR31) 2015; 42 Corces (CR47) 2016; 48 Snyder (CR50) 2014; 371 Moskophidis, Lechner, Pircher, Zinkernagel (CR4) 1993; 362 Utzschneider (CR13) 2016; 45 Barber (CR7) 2006; 439 Gallimore (CR6) 1998; 187 Sade-Feldman (CR38) 2018; 175 Wherry (CR5) 2011; 12 Sen (CR8) 2016; 354 Fidler (CR26) 1975; 35 DeTomaso, Yosef (CR46) 2016; 17 DT Utzschneider (312_CR13) 2016; 45 RM Welsh (312_CR41) 2008; 8 SC Wei (312_CR24) 2017; 170 YA Leong (312_CR16) 2016; 17 MH Jenkins (312_CR27) 2014; 27 EJ Wherry (312_CR11) 2007; 27 JE Schmitz (312_CR36) 1999; 283 AJ Zajac (312_CR3) 1998; 188 L Waltman (312_CR45) 2013; 86 A Gallimore (312_CR6) 1998; 187 CD Carey (312_CR49) 2017; 130 TA Doering (312_CR9) 2012; 37 IJ Fidler (312_CR26) 1975; 35 KE Pauken (312_CR33) 2016; 354 PC Ho (312_CR34) 2015; 162 E Woolf (312_CR30) 2003; 100 M Philip (312_CR23) 2017; 545 D Moskophidis (312_CR4) 1993; 362 J Brummelman (312_CR37) 2018; 215 K Yates (312_CR42) 2018; 115 DL Barber (312_CR7) 2006; 439 L Baitsch (312_CR19) 2011; 121 A Subramanian (312_CR43) 2005; 102 GP Mognol (312_CR10) 2017; 114 SJ Im (312_CR14) 2016; 537 R He (312_CR15) 2016; 537 D DeTomaso (312_CR46) 2016; 17 BL Horton (312_CR35) 2018; 6 PC Tumeh (312_CR32) 2014; 515 MR Corces (312_CR47) 2016; 48 DS Thommen (312_CR39) 2018; 24 A Schietinger (312_CR21) 2016; 45 K Sakuishi (312_CR20) 2010; 207 T Wu (312_CR17) 2016; 1 V Ferreira (312_CR29) 1999; 162 M Ahmadzadeh (312_CR2) 2009; 114 A Snyder (312_CR50) 2014; 371 M Sade-Feldman (312_CR38) 2018; 175 M Sade-Feldman (312_CR40) 2017; 8 EJ Wherry (312_CR5) 2011; 12 JD Buenrostro (312_CR48) 2013; 10 SD Blackburn (312_CR18) 2008; 105 DR Sen (312_CR8) 2016; 354 DS Thommen (312_CR1) 2018; 33 R Satija (312_CR44) 2015; 33 M Singer (312_CR22) 2016; 166 GJ Martinez (312_CR31) 2015; 42 MA Paley (312_CR12) 2012; 338 SD Blackburn (312_CR25) 2009; 10 R Wang (312_CR28) 2011; 187 30846872 - Nat Rev Cancer. 2019 Apr;19(4):185
References_xml	– volume: 8 start-page: 15A.1.1 year: 2008 end-page: 15A.1.11 ident: CR41 article-title: Lymphocytic choriomeningitis virus (LCMV): propagation, quantitation, and storage. publication-title: Curr. Protoc. Microbiol. doi: 10.1002/9780471729259.mc15a01s8 – volume: 10 start-page: 1213 year: 2013 end-page: 1218 ident: CR48 article-title: Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position publication-title: Nat. Methods doi: 10.1038/nmeth.2688 – volume: 8 year: 2017 ident: CR40 article-title: Resistance to checkpoint blockade therapy through inactivation of antigen presentation publication-title: Nat. Commun. doi: 10.1038/s41467-017-01062-w – volume: 537 start-page: 417 year: 2016 end-page: 421 ident: CR14 article-title: Defining CD8 T cells that provide the proliferative burst after PD-1 therapy publication-title: Nature doi: 10.1038/nature19330 – volume: 6 start-page: 14 year: 2018 end-page: 24 ident: CR35 article-title: Intratumoral CD8 T-cell apoptosis is a major component of T-cell dysfunction and impedes antitumor immunity publication-title: Cancer Immunol. Res. doi: 10.1158/2326-6066.CIR-17-0249 – volume: 121 start-page: 2350 year: 2011 end-page: 2360 ident: CR19 article-title: Exhaustion of tumor-specific CD8 T cells in metastases from melanoma patients publication-title: J. Clin. Invest. doi: 10.1172/JCI46102 – volume: 102 start-page: 15545 year: 2005 end-page: 15550 ident: CR43 article-title: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0506580102 – volume: 187 start-page: 5964 year: 2011 end-page: 5973 ident: CR28 article-title: T cell factor 1 regulates thymocyte survival via a RORγt-dependent pathway publication-title: J. Immunol. doi: 10.4049/jimmunol.1101205 – volume: 37 start-page: 1130 year: 2012 end-page: 1144 ident: CR9 article-title: Network analysis reveals centrally connected genes and pathways involved in CD8 . T cell exhaustion versus memory publication-title: Immunity doi: 10.1016/j.immuni.2012.08.021 – volume: 35 start-page: 218 year: 1975 end-page: 224 ident: CR26 article-title: Biological behavior of malignant melanoma cells correlated to their survival in vivo publication-title: Cancer Res. – volume: 515 start-page: 568 year: 2014 end-page: 571 ident: CR32 article-title: PD-1 blockade induces responses by inhibiting adaptive immune resistance publication-title: Nature doi: 10.1038/nature13954 – volume: 338 start-page: 1220 year: 2012 end-page: 1225 ident: CR12 article-title: Progenitor and terminal subsets of CD8 T cells cooperate to contain chronic viral infection publication-title: Science doi: 10.1126/science.1229620 – volume: 100 start-page: 7731 year: 2003 end-page: 7736 ident: CR30 article-title: Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1232420100 – volume: 1 start-page: 1 year: 2016 end-page: 12 ident: CR17 article-title: The TCF1-Bcl6 axis counteracts type I interferon to repress exhaustion and maintain T cell stemness. publication-title: Sci. Immunol. doi: 10.1126/sciimmunol.aai8593 – volume: 42 start-page: 265 year: 2015 end-page: 278 ident: CR31 article-title: The transcription factor NFAT promotes exhaustion of activated CD8 T cells publication-title: Immunity doi: 10.1016/j.immuni.2015.01.006 – volume: 215 start-page: 2520 year: 2018 end-page: 2535 ident: CR37 article-title: High-dimensional single cell analysis identifies stem-like cytotoxic CD8 T cells infiltrating human tumors publication-title: J. Exp. Med. doi: 10.1084/jem.20180684 – volume: 114 start-page: E2776 year: 2017 end-page: E2785 ident: CR10 article-title: Exhaustion-associated regulatory regions in CD8 tumor-infiltrating T cells publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1620498114 – volume: 17 start-page: 1187 year: 2016 end-page: 1196 ident: CR16 article-title: CXCR5 follicular cytotoxic T cells control viral infection in B cell follicles publication-title: Nat. Immunol. doi: 10.1038/ni.3543 – volume: 162 start-page: 1217 year: 2015 end-page: 1228 ident: CR34 article-title: Phosphoenolpyruvate is a metabolic checkpoint of anti-tumor T cell responses publication-title: Cell doi: 10.1016/j.cell.2015.08.012 – volume: 537 start-page: 412 year: 2016 end-page: 428 ident: CR15 article-title: Follicular CXCR5-expressing CD8 T cells curtail chronic viral infection publication-title: Nature doi: 10.1038/nature19317 – volume: 114 start-page: 1537 year: 2009 end-page: 1544 ident: CR2 article-title: Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired publication-title: Blood doi: 10.1182/blood-2008-12-195792 – volume: 439 start-page: 682 year: 2006 end-page: 687 ident: CR7 article-title: Restoring function in exhausted CD8 T cells during chronic viral infection publication-title: Nature doi: 10.1038/nature04444 – volume: 187 start-page: 1383 year: 1998 end-page: 1393 ident: CR6 article-title: Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I–peptide complexes publication-title: J. Exp. Med. doi: 10.1084/jem.187.9.1383 – volume: 162 start-page: 6442 year: 1999 end-page: 6450 ident: CR29 article-title: In vivo inhibition of NF-κB in T-lineage cells leads to a dramatic decrease in cell proliferation and cytokine production and to increased cell apoptosis in response to mitogenic stimuli, but not to abnormal thymopoiesis publication-title: J. Immunol. – volume: 45 start-page: 415 year: 2016 end-page: 427 ident: CR13 article-title: T cell factor 1-expressing memory-like CD8 T cells sustain the immune response to chronic viral infections publication-title: Immunity doi: 10.1016/j.immuni.2016.07.021 – volume: 371 start-page: 2189 year: 2014 end-page: 2199 ident: CR50 article-title: Genetic basis for clinical response to CTLA-4 blockade in melanoma publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1406498 – volume: 105 start-page: 15016 year: 2008 end-page: 15021 ident: CR18 article-title: Selective expansion of a subset of exhausted CD8 T cells by αPD-L1 blockade publication-title: Proc. Natl Acad Sci. USA doi: 10.1073/pnas.0801497105 – volume: 207 start-page: 2187 year: 2010 end-page: 2194 ident: CR20 article-title: Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity publication-title: J. Exp. Med. doi: 10.1084/jem.20100643 – volume: 33 start-page: 495 year: 2015 end-page: 502 ident: CR44 article-title: Spatial reconstruction of single-cell gene expression data publication-title: Nat. Biotechnol. doi: 10.1038/nbt.3192 – volume: 10 start-page: 29 year: 2009 end-page: 37 ident: CR25 article-title: Coregulation of CD8 T cell exhaustion by multiple inhibitory receptors during chronic viral infection publication-title: Nat. Immunol. doi: 10.1038/ni.1679 – volume: 188 start-page: 2205 year: 1998 end-page: 2213 ident: CR3 article-title: Viral immune evasion due to persistence of activated T cells without effector function publication-title: J. Exp. Med. doi: 10.1084/jem.188.12.2205 – volume: 354 start-page: 1160 year: 2016 end-page: 1165 ident: CR33 article-title: Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade publication-title: Science doi: 10.1126/science.aaf2807 – volume: 130 start-page: 2420 year: 2017 end-page: 2430 ident: CR49 article-title: Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed–Sternberg cells in Hodgkin lymphoma publication-title: Blood doi: 10.1182/blood-2017-03-770719 – volume: 283 start-page: 857 year: 1999 end-page: 860 ident: CR36 article-title: Control of viremia in simian immunodeficiency virus infection by CD8 lymphocytes publication-title: Science doi: 10.1126/science.283.5403.857 – volume: 12 start-page: 492 year: 2011 end-page: 499 ident: CR5 article-title: T cell exhaustion publication-title: Nat. Immunol. doi: 10.1038/ni.2035 – volume: 86 year: 2013 ident: CR45 article-title: A smart local moving algorithm for large-scale modularity-based community detection publication-title: Europ. Phys. J. B doi: 10.1140/epjb/e2013-40829-0 – volume: 170 start-page: 1120 year: 2017 end-page: 1133 e1117 ident: CR24 article-title: Distinct cellular mechanisms underlie anti-CTLA-4 and anti-PD-1 checkpoint blockade publication-title: Cell doi: 10.1016/j.cell.2017.07.024 – volume: 354 start-page: 1165 year: 2016 end-page: 1169 ident: CR8 article-title: The epigenetic landscape of T cell exhaustion publication-title: Science doi: 10.1126/science.aae0491 – volume: 27 start-page: 495 year: 2014 end-page: 501 ident: CR27 article-title: Multiple murine BRaf(V600E) melanoma cell lines with sensitivity to PLX4032 publication-title: Pigment. Cell. Melanoma. Res. doi: 10.1111/pcmr.12220 – volume: 115 start-page: 2162 year: 2018 end-page: 2167 ident: CR42 article-title: Comparative transcriptome analysis reveals distinct genetic modules associated with Helios expression in intratumoral regulatory T cells publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1720447115 – volume: 48 start-page: 1193 year: 2016 end-page: 1203 ident: CR47 article-title: Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution publication-title: Nat. Genet. doi: 10.1038/ng.3646 – volume: 166 start-page: 1500 year: 2016 end-page: 1511 e1509 ident: CR22 article-title: A distinct gene module for dysfunction uncoupled from activation in tumor-infiltrating T cells publication-title: Cell doi: 10.1016/j.cell.2016.08.052 – volume: 362 start-page: 758 year: 1993 end-page: 761 ident: CR4 article-title: Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells publication-title: Nature doi: 10.1038/362758a0 – volume: 17 year: 2016 ident: CR46 article-title: FastProject: a tool for low-dimensional analysis of single-cell RNA-Seq data publication-title: BMC Bioinformatics doi: 10.1186/s12859-016-1176-5 – volume: 45 start-page: 389 year: 2016 end-page: 401 ident: CR21 article-title: Tumor-specific T cell dysfunction is a dynamic antigen-driven differentiation program initiated early during tumorigenesis publication-title: Immunity doi: 10.1016/j.immuni.2016.07.011 – volume: 24 start-page: 994 year: 2018 end-page: 1004 ident: CR39 article-title: A transcriptionally and functionally distinct PD-1 CD8 T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade publication-title: Nat. Med. doi: 10.1038/s41591-018-0057-z – volume: 27 start-page: 670 year: 2007 end-page: 684 ident: CR11 article-title: Molecular signature of CD8 T cell exhaustion during chronic viral infection publication-title: Immunity doi: 10.1016/j.immuni.2007.09.006 – volume: 175 start-page: 998 year: 2018 end-page: 1013 e1020 ident: CR38 article-title: Defining T cell states associated with response to checkpoint immunotherapy in melanoma publication-title: Cell doi: 10.1016/j.cell.2018.10.038 – volume: 33 start-page: 547 year: 2018 end-page: 562 ident: CR1 article-title: T cell dysfunction in cancer publication-title: Cancer Cell. doi: 10.1016/j.ccell.2018.03.012 – volume: 545 start-page: 452 year: 2017 end-page: 456 ident: CR23 article-title: Chromatin states define tumour-specific T cell dysfunction and reprogramming publication-title: Nature doi: 10.1038/nature22367 – volume: 33 start-page: 547 year: 2018 ident: 312_CR1 publication-title: Cancer Cell. doi: 10.1016/j.ccell.2018.03.012 – volume: 354 start-page: 1160 year: 2016 ident: 312_CR33 publication-title: Science doi: 10.1126/science.aaf2807 – volume: 114 start-page: E2776 year: 2017 ident: 312_CR10 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1620498114 – volume: 515 start-page: 568 year: 2014 ident: 312_CR32 publication-title: Nature doi: 10.1038/nature13954 – volume: 439 start-page: 682 year: 2006 ident: 312_CR7 publication-title: Nature doi: 10.1038/nature04444 – volume: 27 start-page: 670 year: 2007 ident: 312_CR11 publication-title: Immunity doi: 10.1016/j.immuni.2007.09.006 – volume: 100 start-page: 7731 year: 2003 ident: 312_CR30 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1232420100 – volume: 17 year: 2016 ident: 312_CR46 publication-title: BMC Bioinformatics doi: 10.1186/s12859-016-1176-5 – volume: 362 start-page: 758 year: 1993 ident: 312_CR4 publication-title: Nature doi: 10.1038/362758a0 – volume: 102 start-page: 15545 year: 2005 ident: 312_CR43 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0506580102 – volume: 33 start-page: 495 year: 2015 ident: 312_CR44 publication-title: Nat. Biotechnol. doi: 10.1038/nbt.3192 – volume: 45 start-page: 415 year: 2016 ident: 312_CR13 publication-title: Immunity doi: 10.1016/j.immuni.2016.07.021 – volume: 371 start-page: 2189 year: 2014 ident: 312_CR50 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1406498 – volume: 10 start-page: 29 year: 2009 ident: 312_CR25 publication-title: Nat. Immunol. doi: 10.1038/ni.1679 – volume: 170 start-page: 1120 year: 2017 ident: 312_CR24 publication-title: Cell doi: 10.1016/j.cell.2017.07.024 – volume: 207 start-page: 2187 year: 2010 ident: 312_CR20 publication-title: J. Exp. Med. doi: 10.1084/jem.20100643 – volume: 215 start-page: 2520 year: 2018 ident: 312_CR37 publication-title: J. Exp. Med. doi: 10.1084/jem.20180684 – volume: 1 start-page: 1 year: 2016 ident: 312_CR17 publication-title: Sci. Immunol. doi: 10.1126/sciimmunol.aai8593 – volume: 105 start-page: 15016 year: 2008 ident: 312_CR18 publication-title: Proc. Natl Acad Sci. USA doi: 10.1073/pnas.0801497105 – volume: 188 start-page: 2205 year: 1998 ident: 312_CR3 publication-title: J. Exp. Med. doi: 10.1084/jem.188.12.2205 – volume: 283 start-page: 857 year: 1999 ident: 312_CR36 publication-title: Science doi: 10.1126/science.283.5403.857 – volume: 17 start-page: 1187 year: 2016 ident: 312_CR16 publication-title: Nat. Immunol. doi: 10.1038/ni.3543 – volume: 37 start-page: 1130 year: 2012 ident: 312_CR9 publication-title: Immunity doi: 10.1016/j.immuni.2012.08.021 – volume: 10 start-page: 1213 year: 2013 ident: 312_CR48 publication-title: Nat. Methods doi: 10.1038/nmeth.2688 – volume: 537 start-page: 417 year: 2016 ident: 312_CR14 publication-title: Nature doi: 10.1038/nature19330 – volume: 166 start-page: 1500 year: 2016 ident: 312_CR22 publication-title: Cell doi: 10.1016/j.cell.2016.08.052 – volume: 121 start-page: 2350 year: 2011 ident: 312_CR19 publication-title: J. Clin. Invest. doi: 10.1172/JCI46102 – volume: 162 start-page: 1217 year: 2015 ident: 312_CR34 publication-title: Cell doi: 10.1016/j.cell.2015.08.012 – volume: 130 start-page: 2420 year: 2017 ident: 312_CR49 publication-title: Blood doi: 10.1182/blood-2017-03-770719 – volume: 338 start-page: 1220 year: 2012 ident: 312_CR12 publication-title: Science doi: 10.1126/science.1229620 – volume: 35 start-page: 218 year: 1975 ident: 312_CR26 publication-title: Cancer Res. – volume: 86 year: 2013 ident: 312_CR45 publication-title: Europ. Phys. J. B doi: 10.1140/epjb/e2013-40829-0 – volume: 187 start-page: 5964 year: 2011 ident: 312_CR28 publication-title: J. Immunol. doi: 10.4049/jimmunol.1101205 – volume: 24 start-page: 994 year: 2018 ident: 312_CR39 publication-title: Nat. Med. doi: 10.1038/s41591-018-0057-z – volume: 8 year: 2017 ident: 312_CR40 publication-title: Nat. Commun. doi: 10.1038/s41467-017-01062-w – volume: 354 start-page: 1165 year: 2016 ident: 312_CR8 publication-title: Science doi: 10.1126/science.aae0491 – volume: 545 start-page: 452 year: 2017 ident: 312_CR23 publication-title: Nature doi: 10.1038/nature22367 – volume: 8 start-page: 15A.1.1 year: 2008 ident: 312_CR41 publication-title: Curr. Protoc. Microbiol. doi: 10.1002/9780471729259.mc15a01s8 – volume: 45 start-page: 389 year: 2016 ident: 312_CR21 publication-title: Immunity doi: 10.1016/j.immuni.2016.07.011 – volume: 537 start-page: 412 year: 2016 ident: 312_CR15 publication-title: Nature doi: 10.1038/nature19317 – volume: 48 start-page: 1193 year: 2016 ident: 312_CR47 publication-title: Nat. Genet. doi: 10.1038/ng.3646 – volume: 115 start-page: 2162 year: 2018 ident: 312_CR42 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1720447115 – volume: 162 start-page: 6442 year: 1999 ident: 312_CR29 publication-title: J. Immunol. doi: 10.4049/jimmunol.162.11.6442 – volume: 27 start-page: 495 year: 2014 ident: 312_CR27 publication-title: Pigment. Cell. Melanoma. Res. doi: 10.1111/pcmr.12220 – volume: 12 start-page: 492 year: 2011 ident: 312_CR5 publication-title: Nat. Immunol. doi: 10.1038/ni.2035 – volume: 42 start-page: 265 year: 2015 ident: 312_CR31 publication-title: Immunity doi: 10.1016/j.immuni.2015.01.006 – volume: 175 start-page: 998 year: 2018 ident: 312_CR38 publication-title: Cell doi: 10.1016/j.cell.2018.10.038 – volume: 114 start-page: 1537 year: 2009 ident: 312_CR2 publication-title: Blood doi: 10.1182/blood-2008-12-195792 – volume: 6 start-page: 14 year: 2018 ident: 312_CR35 publication-title: Cancer Immunol. Res. doi: 10.1158/2326-6066.CIR-17-0249 – volume: 187 start-page: 1383 year: 1998 ident: 312_CR6 publication-title: J. Exp. Med. doi: 10.1084/jem.187.9.1383 – reference: 30846872 - Nat Rev Cancer. 2019 Apr;19(4):185
SSID	ssj0014764
Score	2.7246602
Snippet	T cell dysfunction is a hallmark of many cancers, but the basis for T cell dysfunction and the mechanisms by which antibody blockade of the inhibitory receptor...
SourceID	pubmedcentral proquest pubmed crossref springer
SourceType	Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	326
SubjectTerms	631/250/1619/554/1834/1269 631/250/2502/2170 631/250/580 692/699/67/1059/2325 Animals Antibodies, Blocking - immunology Antibodies, Blocking - pharmacology Biomedical and Life Sciences Biomedicine CD8 antigen CD8-Positive T-Lymphocytes - drug effects CD8-Positive T-Lymphocytes - immunology CD8-Positive T-Lymphocytes - virology Cell Line, Tumor Chronic infection Cytotoxicity Epigenetics Female Humans Immune checkpoint Immunology Infectious Diseases Lymphocyte Subsets - drug effects Lymphocyte Subsets - immunology Lymphocyte Subsets - virology Lymphocytes Lymphocytes T Lymphocytes, Tumor-Infiltrating - drug effects Lymphocytes, Tumor-Infiltrating - immunology Lymphocytes, Tumor-Infiltrating - virology Lymphocytic Choriomeningitis - immunology Lymphocytic Choriomeningitis - prevention & control Lymphocytic Choriomeningitis - virology Lymphocytic choriomeningitis virus - drug effects Lymphocytic choriomeningitis virus - immunology Lymphocytic choriomeningitis virus - physiology Melanoma Melanoma, Experimental - immunology Melanoma, Experimental - prevention & control Melanoma, Experimental - virology Mice, Congenic Mice, Inbred C57BL PD-1 protein Programmed Cell Death 1 Receptor - antagonists & inhibitors Programmed Cell Death 1 Receptor - immunology Programmed Cell Death 1 Receptor - metabolism Transcription Tumor-infiltrating lymphocytes
Title	Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade
URI	https://link.springer.com/article/10.1038/s41590-019-0312-6 https://www.ncbi.nlm.nih.gov/pubmed/30778252 https://www.proquest.com/docview/2183741346 https://www.proquest.com/docview/2475058418 https://www.proquest.com/docview/2183650912 https://pubmed.ncbi.nlm.nih.gov/PMC6673650
Volume	20
WOSCitedRecordID	wos000458893600017&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1529-2916 dateEnd: 20211231 omitProxy: false ssIdentifier: ssj0014764 issn: 1529-2908 databaseCode: M7P dateStart: 20000701 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1529-2916 dateEnd: 20211231 omitProxy: false ssIdentifier: ssj0014764 issn: 1529-2908 databaseCode: 7X7 dateStart: 20000701 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1529-2916 dateEnd: 20211231 omitProxy: false ssIdentifier: ssj0014764 issn: 1529-2908 databaseCode: BENPR dateStart: 20000701 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1529-2916 dateEnd: 20211231 omitProxy: false ssIdentifier: ssj0014764 issn: 1529-2908 databaseCode: 8C1 dateStart: 20000701 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR1Nb9Mw1GIbIC58jDEKozISJyZrie3E9glB2cQBqgoNqbfIcWytWklKk07s3_PsfKAybRcuPuQ5lp337ffyHkLv0tyAFU9TIpKEER47R1SaOCKY0omwXBsXupZ8FdOpnM_VrLtwq7u0yl4mBkFdVMbfkZ9QDroNtGUsP6x-Ed81ykdXuxYaO2jPV0lgIXVvNkQRuAjlo0BFKUJVJPuoJpMnNSgu5VOyFAGypiTd1ks3jM2bOZP_BE6DPjp78r8neYoed5Yo_tiSzjN0z5b76EHbm_J6Hz381kXdn6OFly62qXHlsP194SsF2QJPPstjfI79zX-N-z4rIC-Wy2sc_kdpLG42P6s17tLhsS4LvA45uQVuKgzkYi5X1aJscA4q9VIX9gD9ODs9n3whXYsGYriSDUksuLg8cjqPmWYavDHhRKSEKTQ1kdJGasfz1FLmHNgWhsIzXfBYCJtaTSP2Au2WVWlfImzA8wL3S0oucy6dyo12NNfWREZEcV6MUNQjKDNd_XLfRmOZhTg6k1mL0wxwmnmcZukIvR9eWbXFO-6afNSjK-v4uM68AQk2F-O3gAdUjtDbAQwM6r-9Lm21aZfwZQpjOkKHLQ0NmwEBCxZaAhCxRV3DBF_8extSLi5CEXDfrhWWHaHjng7_buvWM766-xCv0SPacgQwxhHabdYb-wbdN1fNol6P0Y6YizBKGOUkHqO9T6fT2fdx4Lo_dEsuhw
linkProvider	ProQuest
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6V8rzwKK-FAkaCC5XVxHFi54AQaqladbvqYZF6Sx3HVlddkmWTBfZP8RsZ54WWqr31wDXjWLbzzSszngF4F6UarXgWURGGAeW-tTSOQktFEKtQGK60rbuWDMVoJE9O4uM1-N3dhXFplZ1MrAV1Vmj3j3ybcdRtqC19-Wn2nbquUS662rXQaGBxaJY_0WUrPx7s4vd9z9jel_HOPm27ClDNY1nR0KBXxj2rUj9QgUIHQljhxUJnimkvVloqy9PIsMBaVIea4TOVcV8IExnFvADnvQE30Yxgsk4VPO6jFlzU5apQJcaUxZ7soqiB3C5RUcYuBSymyEaMRqt68IJxezFH859Aba3_9h78byf3EO63ljb53LDGI1gz-QbcbnpvLjfgzlGbVfAYJk56mqokhSXm15mrhGQysrMrt8iYuMhGSbo-MigPp9Mlqe_bVIZUi2_FnLTp_kTlGZnXOccZqQqC7KDPZ8Ukr0iKJsO5yswT-HotW34K63mRm-dANHqW6F5KyWXKpY1TrSxLldGeFp6fZgPwOkAkuq3P7tqETJM6TyCQSYOhBDGUOAwl0QA-9K_MmuIkVw3e7OCRtHKqTJyBjDZlwC8h99AZwNuejALInb3KTbFopnBlGH02gGcNZvvFoAJBCzREilhBcz_AFTdfpeSTs7rIuWtHi9MOYKvD_d9lXbrHF1dv4g3c3R8fDZPhwejwJdxjDTciU27CejVfmFdwS_-oJuX8dc3XBE6vmx3-AMS7h-c
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VAhUXHqXAQgEjwYUq2sRxYvuAENqlompZ9VCk3oLj2OqqS7JsssD-NX4d47zQUrW3HrjGjmU73zePeDwD8DpONVrxNPZ4FIUeC6z1ZBxZj4dSRdwwpW1dteSITybi9FQeb8Dv7i6MC6vsZGItqLNCu3_kQ8pQt6G2DMTQtmERx-P99_Pvnqsg5U5au3IaDUQOzeonum_lu4Mxfus3lO5_PBl98toKA55mUlReZNBDY75VaRCqUKEzwS33JdeZotqXSgtlWRobGlqLqlFTfKYyFnBuYqOoH-K4N-AmDxHF7pb6qA8vCRivU1ehepQelb7oTlRDMSxRaUoXDiY9pBT14nWdeMHQvRiv-c-hba0L9-_9z7t4H-62Fjj50FDmAWyYfBtuNzU5V9uw9bmNNngIUydVTVWSwhLz68xlSDIZGY3FHjkh7sSjJF19GZSTs9mK1PdwKkOq5bdiQdprAETlGVnUscgZqQqCNNHn82KaVyRFU-JcZWYHvlzLkh_BZl7k5gkQjR4nup1CMJEyYWWqlaWpMtrX3A_SbAB-B45Et3nbXfmQWVLHD4QiafCUIJ4Sh6ckHsDb_pV5k7Tkqs67HVSSVn6ViTOc0dYM2SXNPYwG8KpvRsHk9l7lplg2Q7j0jAEdwOMGv_1kULGgZRphC19Ddt_BJT1fb8mnZ3Xyc1emFocdwF7Hgb_TunSNT69exEvYQhYkRweTw2dwhzbERH7uwma1WJrncEv_qKbl4kVNcQJfr5sNfwC5zZBd
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Subsets+of+exhausted+CD8%2B+T+cells+differentially+mediate+tumor+control+and+respond+to+checkpoint+blockade&rft.jtitle=Nature+immunology&rft.au=Miller%2C+Brian+C.&rft.au=Sen%2C+Debattama+R.&rft.au=Abosy%2C+Rose+Al&rft.au=Bi%2C+Kevin&rft.date=2019-03-01&rft.issn=1529-2908&rft.eissn=1529-2916&rft.volume=20&rft.issue=3&rft.spage=326&rft.epage=336&rft_id=info:doi/10.1038%2Fs41590-019-0312-6&rft_id=info%3Apmid%2F30778252&rft.externalDocID=PMC6673650
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1529-2908&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1529-2908&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1529-2908&client=summon